CURRICULUM VITAE - Harvard Medical School...3/20/2014 CURRICULUM VITAE Name: SHARON BOEHM MURPHY...

3/20/2014

CURRICULUM VITAE

Name: SHARON BOEHM MURPHY

Academic Degrees:

B.S. 1965 University of Wisconsin, Madison, Wisconsin

M.D. cum laude 1969 Harvard University, Boston, Massachusetts

Professional Appointments:

1969-70 Intern in Pediatrics, University of Colorado Medical Center, Denver, Colorado

1970-71 Resident in Pediatrics, University of Colorado Medical Center, Denver, Colorado

1971-72 Postdoctoral Trainee in Pediatric Hematology, University of Pennsylvania, Children's Hospital of Philadelphia

1972-73 Postdoctoral Trainee in Pediatric Oncology, University of Pennsylvania, Children's Hospital of Philadelphia

1974-76 Research Associate in Hematology/Oncology, St. Jude Children's Research Hospital, and Assistant Professor of

Pediatrics, University of Tennessee College of Medicine, Memphis, Tennessee

1976-78 Assistant Member in Hematology/Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee

1979-85 Associate Member in Hematology/Oncology, St. Jude Children's Research Hospital, and Associate Professor of

Pediatrics, University of Tennessee, Center for the Health Sciences, Memphis, Tennessee

1985-88 Member in Hematology/Oncology, St. Jude Children's Research Hospital, and Professor of Pediatrics, University

of Tennessee, Center for the Health Sciences, Memphis, Tennessee

1988-02 Chief of the Division of Hematology/Oncology, Children's Memorial Hospital, and Professor of Pediatrics,

Northwestern University Medical School, Chicago, Illinois

2002-2008 Director, Children’s Cancer Research Center, and Professor of Pediatrics, University of Texas Health Science

Center at San Antonio

2008-2013 Scholar-in-Residence, Institute of Medicine, Washington, D.C.

Certification:

National Board of Medical Examiners - 1970

American Board of Pediatrics - 1974, Recertification - 1990

Sub-Board of Pediatric Hematology-Oncology - 1974, Recertification - 1990

Medical Licensures:

Tennessee

Illinois

Texas

Research Interests:

Non-Hodgkin's lymphomas and acute lymphoblastic leukemias, biology and therapy

National Committees:

1975-77 Member, Combined Modalities Clinical Trials Committee, Division of Cancer Treatment, National Cancer

Institute

1978-82 Member, Board of Scientific Counselors, Division of Cancer Treatment, National Cancer Institute

1980-82 Member, U.S. Committee for Cancer Clinical Research, U.S.-France (NCI-INSERM) Cancer Program

1984-88 Member, Cancer Therapeutics Program Project Review Committee, Division of Extramural Activities, NCI/NIH

1985-89 Member, Grant Review Subcommittee, Leukemia Society of America

1986-91 Member, Sub-Board of Pediatric Hematology-Oncology of the American Board of Pediatrics

1986-90 Member, Board of Directors, Director-at-Large, American Cancer Society (ACS)

1986-93 Member, ACS National Task Force on Children and Cancer

1986-90 Member, ACS Medical and Scientific Committee

of 32

1986-90 Member, ACS Professional Education Committee

1988-92 Member, Reviewers Reserve, NIH, Division of Research Grants

1989-92 Chairperson, American Association of Pediatric Hematology/Oncology Training Program Directors

1992-93 Member, Kettering Selection Committee, General Motors Cancer Research Foundation Awards

1993 Member, Task Force on AIDS Malignancies, NCI/NIAID, NIH

1994-02 Member, Accreditation Appeals Panel in Pediatric Hematology-Oncology, Accreditation Council for Graduate

Medical Education (ACGME)

1994-97 Councillor, Harvard Medical Alumni Association

1997-99 President-Elect, Harvard Medical Alumni Association

1996-98 Member, NCI Working Group on Developmental Diagnostics

1996-98 Member, WHO Clinical Advisory Committee to Working Group for Classification of Neoplastic Diseases of the

Hematopoietic and Lymphoid Tissues

1996-99 Member, Board of Scientific Advisors, NCI

1996-00 Member, Awards Assembly, General Motors Cancer Research Foundation

1997-01 Founding Director, Coalition of National Cancer Cooperative Groups, Inc.

1998-02 Member, External Scientific Advisory Board of the Comprehensive Cancer Center at the Ohio State University

1999-2013 Member, Professional Advisory Board, Children’s Cause for Cancer Advocacy

1999-00 President, Harvard Medical Alumni Association

2000-01 Member, NCI Leukemia, Lymphoma, and Myeloma Progress Review Group

2001-04 Member, Standing Review Panel, Medical Research Program, Doris Duke Charitable Foundation

2002-05 Member, Scientific Advisory Board, Lymphoma Research Foundation

2004-2008 Member, Scientific Advisory Board, Childhood Cancer Survivor Study, an NCI-funded resource

2004-08 Member, Advisory Board, Texans for Advancement of Medical Research

2004-2010 Consultant, Oncologic Drug Advisory Committee, Center for Drug Evaluation, FDA, HHS

2005-06 Member, Advisory Council on Medical Education, Harvard Medical School

2006-07 Member, Special Emphasis Panel, NCI, for review of applications for NIH Loan Repayment Program (LRP)

2010 Member, Translational Research Program-Quality of Life Subcommittee Review Panel, Leukemia &Lymphoma

Society

2010-12 Member, Standing Committee of the Newborn Screening Translational Research Network, American College of

Medical Genetics

Editorial Boards:

1979-96 Member, Editorial Board, Seminars in Oncology

1982-86 Member, Advisory Board, CRC Critical Reviews in Oncology/Hematology

1989-92,1993-96 Member, Editorial Board, Journal of Clinical Oncology

1989-1993 Associate Editor, Cancer Research

1989-1995 Member, Editorial Board, Current Opinions in Oncology, Current Science

1990-94 Member, Editorial Board, Contemporary Oncology

1993-97 Member, Editorial Board, Oncology: International Journal of Cancer Research and Treatment

1993-96 Member, Editorial Board, Pediatric Hematology and Oncology

1994-98 Associate Editor, Clinical Cancer Research

1994-2002 Member, Editorial Board, Journal of Pediatric Hematology/Oncology

Societies:

Phi Beta Kappa

Alpha Omega Alpha

American Academy of Pediatrics

American Society of Hematology

Member, Subcommittee on Pediatric Hematology - 1980-84

Member, Committee on Public Information and Governmental Affairs, 1997-2001

Member, Nominating Committee, 2000-2001

Member, Committee on Investment and Audit, 2001-2002

Member, ad hoc Minority Committee, 2003-2006

Councillor, 2003-2006

Chairman, Awards Committee, 2007-2009

of 32

American Society of Clinical Oncology

Member, Program Committee - 1979, 1984

Chairman, Nominating Committee - 1980

Chairman, Awards Committee - 1983-85

Board of Directors - 1982-85

Member, Scientific and Publications Committee - 1984-89

Chairman, Scientific and Publications Committee - 1987-89

Member, Oncology Training Committee - 1988 to 1992

Member, Strategic Planning Committee - 1989-90

Member, Public Issues Committee - 1989-94

Member, Nominating Committee - 1994-9

Member, Search Committee for Editor, Journal of Clinical Oncology, 1999-2000

Member, Government Relations Committee, 2011-2013

American Association for Cancer Research

Member, Program Committee - 1983, 1994, 2005

Member, Nominating Committee, 1984

Member, Rosenthal Award Selection Committee, 1990, 1991, 1997

Board of Directors, 1991-94

Chair, Task Force on Clinical Investigation, 1992

Member, Public Education Committee, 2000

Member, Science Policy and Legislative Affairs Committee, 2001-2002

Member, Pediatric Oncology Task Force, 2003-2008

Member, Brigid G. Leventhal Scholar Awards Committee, 2003-2004

Member, Dorothy P. Landon – AACR Prize for Translational Cancer Research Committee, 2005

The Cell Kinetic Society

Councilor - 1982-84

Society for Pediatric Research

American Society of Pediatric Hematology and Oncology

Chair, Strategic Planning Committee, 1991-92

Member, Corporate Liasons Committee, 2002-2004

International Society of Pediatric Oncology, (Societé Internationale D'Oncologie Pediatrique, SIOP) 1992-2008

Women in Cancer Research

National Clinical Cooperative Group Activities:

Pediatric Oncology Group

1981-01 Member

1981-92 Chairperson, Non-Hodgkin's Lymphoma Committee

1989-92 Member, Principal Investigator's Core Committee

1992-93 Vice-Chairman, Chair-Elect

1993-01 Chairperson

Citations, Honors:

Listing, Who’s Who in America, Marquis, 2007

Listing, The Best Doctors in America, Woodward/White Inc. in 1992-93, 1994-95, 1998-99, and 2003-2004

Listing, The Best Doctors in America, American Health Magazine, Pg. 61-82, March, 1996

Listing, America’s Top Doctors, Castle Connally, Ltd., 2004, 2005, 2006, 2007, 2010

Clinical Research Award, Association of Community Cancer Centers, 2001

Return of the Child Award, Leukemia and Lymphoma Society, November 2002

of 32

Distinguished Service Award for Scientific Leadership, American Society of Clinical Oncology, 2005

Women’s Leadership Award, non-profit leadership, San Antonio Business Journal, 2006

Statesman Award, American Society of Clinical Oncology, 2007

Distinguished Career Award, American Society of Pediatric Hematology/Oncology, 2009

Pediatric Oncology Award, American Society of Clinical Oncology, 2010

Publications:

Original Articles

1. Lower, G., Murphy, S., and Bryan, G.T.: Utilization of ion exchange chromatography in the isolation and calorimetric

assay of p-aminophenol glucuronide derivatives in human urine. Clin. Chem. Acta 29:421-427, 1970.

2. Murphy, S. and Lubin, B.: Triphalangeal thumbs and congenital erythroid hypoplasia: Report of a case with unusual

features. J. Pediatr. 81:987, 1972.

3. Murphy, S. and Oski, F.A.: Congenital dyserythropoietic anemia, Type II. Report of two cases and a review of the

literature. Pediatrics 50:858, 1972.

4. Murphy, S.B., Frizzera, G., and Evans, A.E.: A study of childhood non-Hodgkin's lymphoma. Cancer 36:2121-2131,

1975.

5. Murphy, S.B., Borella, L., Sen, L., and Mauer, A.: Lack of correlation of lymphoblast cell size with presence of T-cell

markers or with outcome in childhood acute lymphoblastic leukemia. Br. J. Hematol. 31:95, 1975.

6. Murphy, S.B., Aur, R.J.A., Simone, J.V., George, S. and Mauer, A.M.: Pretreatment cytokinetic studies in 94 children with

acute leukemia. Relationship to other variables at diagnosis and to outcome of standard treatment. Blood 49:683-691,

1977.

7. Ransom, J.L. and Murphy, S.B.: Histiocytosis X: Abnormal cerebrospinal fluid cytology in extrahypothalamic central

nervous system involvement. A case report. South. Med. J. 70:1367-1369, 1977.

8. Rivera, G., Murphy, S.B., Aur, R.J.A., Verzosa, M.S., Dahl, G.V., and Mauer, A.M.: Recurrent childhood lymphocytic

leukemia: Clinical and cytokinetic studies of cytosine arabinoside and methotrexate for maintenance of second

hematologic remission. Cancer 42.2521-2528, 1978.

9. Murphy, S.B., Melvin, S.L., and Mauer, A.M.: Correlation of tumor cell kinetic studies with surface marker results in

childhood non-Hodgkin's lymphomas. Cancer Res. 39:1534-1538, 1979.

10. Frizzera, G. and Murphy, Sharon B.: Follicular (nodular) lymphoma in childhood: A rare clinical-pathological entity.

Cancer 44:2218-2235, 1979.

11. Brodeur, G.M., Wilber, R.B., Melvin, S.L., and Murphy, S.B.: Histoplasmosis mimicking childhood non-Hodgkin's

lymphoma. Med. Pediatr. Oncol. 7:77-81, 1979.

12. Murphy, S.B. and Hustu, H.O.: A randomized trial of combined modality therapy of childhood non-Hodgkin's lymphoma.

Cancer 45:630-637, 1980.

13. Poplack, D.G., Sallan, S.E., Rivera, G., Holcenberg, J., Murphy, S.B., Blatt, J., Lipton, J.M., Venner, P., Glaubiger, D.L.,

Ungerleider, R., and Johns, D.: Phase I study of 2'-deoxycoformycin in acute lymphoblastic leukemia. Cancer Res.

41:3343-3346, 1981.

14. Venner, P.M., Glazer, R.I., Blatt, J., Sallan, S., Rivera, G., Holcenberg, J.S., Lipton, J., Murphy, S.B., and Poplack, D.G.:

Levels of 2'-deoxycoformycin, adenosine, and deoxyadenosine in patients with acute lymphoblastic leukemia. Cancer

Res. 41:4508-4511, 1981.

of 32

15. Evans, W.E., Tsiatis, A., Rivera, G., Murphy, S.B., Dahl, G.V., Denison, M., Crom, W.R., Barker, L.F., and Mauer, A.M.:

Anaphylactoid reactions to E. coli and Erwinia asparaginase in children with leukemia and lymphoma. Cancer 49:1378-

1383, 1982.

16. Pui, C.-H., Williams, D.H., Scarborough, V., Jackson, C., Price, R., and Murphy, S.: Acute megakaryoblastic leukemia

associated with intrinsic platelet dysfunction and constitutional ring 21 chromosome in a young boy. Br. J. Hematol.

50:191-200, 1982.

17. Naegele, R.F., Champion, J., Murphy, S., Henle, G., and Henle, W.: Nasopharyngeal carcinoma in American children:

Epstein-Barr virus-specific antibody titers and prognosis. Int. J. Cancer 29(2):209-212, 1982.

18. Bernard, A., Murphy, S.B., Melvin, S., Bowman, W.P., Cailaud, J., Lemerle, J., and Boumsell, L.: Non-T, non-B

lymphomas are rare in childhood and associated with cutaneous tumor. Blood 59:549-554, 1982.

19. Look, A.T., Melvin, S.L., Williams, D.L., Brodeur, G.M., Dahl, G.V., Kalwinsky, D.K. Murphy, S.B., and Mauer, A.M.:

Aneuploidy and percentage of S-phase cells determined by flow cytometry correlate with cell phenotype in childhood

acute leukemia. Blood 60:959-967, 1982.

20. Dahl, G.V., Kalwinsky, D.K., Murphy, S., Look, A.T., Amadori, S., Kumar, M., Novak, R., George, S., Mason, C., Mauer,

A.M., and Simone, J.V.: Cytokinetically based induction chemotherapy and splenectomy in childhood acute

nonlymphocytic leukemia. Blood 60:856-863, 1982.

21. Murphy, S.B., Dahl, G.V., George, S.L., Karas, J., Look, A.T., Simone, J.V., and Mauer, A.M.: Determination of the

significance of invitro blast cell {3H]-thymidine labeling indices obtained initially and serially during induction therapy

of acute nonlymphocytic leukemia. Leuk. Res. 6(5):639-648, 1982.

22. Ch'ien, L.T., Kalwinsky, D.K., Patterson, D.O., Pratt, C.B., Murphy, S.B., Hayes, F.A., Green, A.A., and Hustu, H.O.:

Metastatic epidural tumors in children. Med. Pediatr. Oncol. 10:455-462, 1982.

23. Rivera, G., Bowman, W.P., Murphy, S.B., Dahl, G.V., Aur, R.J., Kalwinsky, D.K., Wood, A., Stagner, S., and Avery, T.L:

VM-26 with prednisone and vincristine for treatment of refractory acute lymphocytic leukemia. Med. Pediatr. Oncol.

10:439-446, 1982.

24. Gallo, R.C., Kalyanaraman, V.S., Sarngadharan, M.G., Sliski, A., Vonderheid, E.C., Maeda, M., Nakao, Y., Yamada, K.,

Ito, Y., Gutensohn, N., Murphy, S., Bunn, P.A., Jr., Catovsky, D., Greaves, M.F., Blayner, D.W., Blattner, W., Jarrett,

W.F.H., zur Hausen, H., Seligmann, M., Brouet, J.C., Haynes, B.F., Jegasothy, B.V., Jaffe, E., Cossman, J., Broder, S.,

Fisher, R.I., Golde, D.W., and Robert-Guroff, M.: Association of the human type C retrovirus with a subset of adult T-cell

cancers. Cancer Res. 43:3892-99, 1983.

25. Murphy, S.B., Hustu, H.O., Rivera, G., and Berard, C.W.: End results of treating children with localized non-Hodgkin's

lymphomas with a combined modality approach of lessened intensity. J. Clin. Oncology 1:326-330, 1983.

26. Murphy, S.B., Stass, S., Kalwinsky, D., and Rivera, G.: Phenotypic conversion of acute leukemia from T-lymphoblastic to

myeloblastic induced by therapy with 2'-deoxycoformycin. Br. J. Hematol. 55:285-293, 1983.

27. Pui, C.-H., Costlow, M.E., Dahl, G.V., Rivera, G., and Murphy, S.B.: Response of recurrent acute lymphoblastic

leukemia to glucocorticoids: Serial studies of receptor content, in vivo cytokinetic changes and clinical responses. Leuk.

Res. 7:747-753, 1983.

28. Pui, C.-H., Dahl, G.V., Melvin, S., Williams, D.L., Peiper, S., Mirro, J., Murphy, S.B., and Stass, S.: Acute leukemia with

mixed lymphoid and myeloid phenotype. Br. J. Hematol. 56:121-130, 1984.

29. Murphy, S.B.: Therapy of localized non-Hodgkin's lymphoma in children. (Letter to Editor). J. Clin. Onc. 2:140-141,

1984.

30. Murphy, S.B., Sinkule, J.A., and Rivera, G.: A Phase I-II clinical and pharmacodynamic study of the effects of

2'deoxycoformycin (NSC-218321) administered by continuous intravenous infusion in children with refractory acute

lymphoblastic leukemia. Cancer Treatment Symposia 2:55-61, 1984.

of 32

31. Murphy, S.B., Herrod, H.G., Sinkule, J., Abromowitch, M., and Rivera, G.: Severe combined immunodeficiency and

profound weight loss associated with chronic intermittent administration of 2'-deoxycoformycin (NSC-218321). Cancer

Treatment Symposia 2:63-66, 1984.

32. Look, A.T., Melvin, S.L., Brown, L.K., Dockter, M.E., Roberson, P.K., and Murphy, S.B.: Quantitative variation of the

common acute lymphoblastic leukemia antigen (gp 100) on leukemic marrow blasts. J. Clin. Invest. 73:1617-1628, 1984.

33. Rovigatti, U., Mirro, J., Kitchingman, G., Dahl, G., Ochs, J., Murphy, S., and Stass, S.: Heavy chain immunoglobulin

gene rearrangement in acute nonlymphocytic leukemia. Blood 63:1023-1027, 1984.

34. Sackey, K., Odone, V., George, S., and Murphy, S.: Poland's syndrome associated with childhood non-Hodgkin's

lymphoma. Am. J. Dis. Child. 138-600-601, 1984.

35. Murphy, S.B., Harris, A. and Williams, D.L.: Chromosomal translocations and timing of malignant transformation in

Burkitt's lymphoma. (Letter to the editor). N. Engl. J. Med. 311:195-196, 1984.

36. Pui, C-H., Dahl, G.V., Rivera, G., Murphy, S.B., and Costlow, M.E.: The relationship of blast cell glucocorticoid

receptor levels to response to single agent steroid trial and remission response in children with acute lymphoblastic

leukemia. Leuk. Res. 8:579-585, 1984.

37. Stass, S., Mirro, J., Melvin, S., Pui, C-H., Murphy, S.B., and Williams, D.: Lineage switch in acute leukemia. Blood

64:701-706, 1984.

38. Stass, S., Pui, C.-H., Melvin, S., Rovigotti, U., Murphy, S., Williams, D., Motroni, T., Kalwinsky, D., and Dahl, G.V.:

Sudan black B positive acute lymphoblastic leukemia. Br. J. Hematol. 57:121-130, 1984.

39. Pui, C.-H., Dahl, G.V., Melvin, S., Williams, D.L., Peiper, S., Mirro, J., Murphy, S.B., and Stass, S.: Acute leukemia with

mixed lymphoid and myeloid phenotype. (Letter) Br. J. Hematol. 58:204-205, 1984.

40. Kitchingman, G.R., Rovigatti, U., Mauer, A.M., Melvin, S., Murphy, S.B., and Stass, S.: Rearrangement of

immunoglobulin heavy chain genes in T-cell acute lymphoblastic leukemia. Blood 65:725-729, 1985.

41. Mirro, J., Kalwinsky, D., Whisnant, J., Weck, P., Chesney, C., and Murphy, S.B: Coagulopathy induced by high dose

continuous infusion of high doses of human lymphoblastoid interferon (Wellferon). Cancer Treat. Rep. 69:315-317,

1985.

42. Rivera, G., Evans, W.E., Kalwinsky, D.K., Mirro, J., Ochs., Dow, L.W., Abromowitch, M., Pui, C.-H., Dahl, G.V., Look,

A.T., Crone M. and Murphy, S.B.: Unexpectedly severe toxicity from high-dose methotrexate in early treatment of

childhood lymphoblastic leukemia. J. Clin. Oncol. 3:201-206, 1985.

43. Kalwinsky, D.K., Roberson, P., Dahl, G., Harber, J., Rivera, G., Bowman, W.P., Pui, C-H, Ochs, J., Abromowitch, M.,

Costlow, M.E., Melvin, S.L., Stass, S., Williams, D.L. and Murphy, S.B.: Clinical relevance of lymphoblasts biologic

features in children with acute lymphoblastic leukemia. J. Clin. Oncol. 3:477-484, 1985.

44. Look, A.T., Roberson, P.K., Williams, D.L., Rivera, G., Bowman, W.P., Pui, C.-H., Ochs, J., Abromowitch, M., Kalwinsky,

D., Dahl, G.V., George, S., and Murphy, S.B.: Prognostic importance of blast cell DNA content in childhood acute

lymphoblastic leukemia. Blood 65:1079-1086, 1985.

45. Mirro, J., Kitchingman, G., Stass, S., and Murphy, S.B.: Heavy-chain immunoglobulin gene rearrangement and lineage

infidelity in acute myelocytic leukemia (Letter). Blood 65:1294-1295, 1985.

46. Pui, C-H, Dahl , G.V., Hustu, H.O. and Murphy, S.B.: Epidural spinal cord compression as a presenting feature of

childhood acute leukemia and non-Hodgkin's lymphomas. J. Pediatr. 106:788-792, 1985.

47. Kalwinsky, D.K., Rivera, G., Dahl, G.V., Roberson, P., George, S., Murphy, S.B., and Simone, J.V.: Variation by race in

presenting clinical and biologic features in childhood acute lymphoblastic leukemia: Implications for treatment outcome.

Leuk. Res. 9:817-823, 1985.

of 32

48. Williams, D., Raimondi, S., Rivera, G., George, S., Berard, C., and Murphy, S.: Clonal chromosomal abnormalities may

be present in virtually all cases of acute lymphoblastic leukemia. (Letter to the Editor.) N. Engl. J. Med. 313:640-641,

1985.

49. Dahl, G.V., Rivera, G., Pui, C-H., Mirro Jr., J., Ochs, J., Kalwinsky, D.K., Abromowitch, M., Look, A.T., and Murphy,

S.B.: A novel treatment for childhood lymphoblastic non-Hodgkin's lymphoma. Blood 66:1110-1114, 1985.

50. Pui, C-H., Rivera, G., Mirro, J., Stass, S., Peiper, S., Murphy, S.B.: Acute megakaryoblastic leukemia: Blast cell

aggregates simulating metastatic tumor. Arch. Pathol. Lab. Med. 109:1033-1035, 1985.

51. Pui, C-H., Dodge, R.K., Dahl, G.V., Rivera, G., Look, A.T., Kalwinsky, D., Bowman, W.P., Ochs, J., Abromowitch, M.,

Mirro, J., and Murphy, S.B.: Serum lactic dehydrogenase levels has prognostic value in childhood acute lymphoblastic

leukemia. Blood 66:778-782, 1985.

52. Mirro, J., Zipf, T.F., Pui, C-H., Kitchingman, G., Williams, D., Melvin, S., Murphy, S.B., and Stass, S.: Acute mixed

lineage leukemia: clinico-pathologic correlations and prognostic significance. Blood 66:11154-1123, 1985.

53. Murphy, S. B., Raimondi, S.C., Williams, D.L., Carroll, A.J., Castleberry, R.P., and Crist, W.N.: Abnormalities of the

short arm of chromosome 9 and lymphomatous leukemia. (Letter to the Editor). N. Engl. J. Med. 313:1611, 1985.

54. Murphy, S.B., Yatsula, K., Thompson, E.I., Hayes, F.A., and Simone, J.V.: Life after cancer. (Letter to the Editor) N.

Engl. J. Med. 314(3):188, 1986.

55. Kitchingman, G.R., Mirro, J., Stass, S.A., Rovigatti, U., Melvin, S.L., Williams, D.L., Raimondi, S., and Murphy, S.B.:

Biologic and prognostic significance of the presence of more than two heavy chain genes in childhood acute

lymphoblastic leukemia of B- precursor cell origin. Blood 67:698-703, 1986.

56. Mirro, J., Dow, L.W., Kalwinsky, D., Dahl, G.V., Weck, P., Whisnant, J., and Murphy, S.B.: A phase I-II study of

continuous- infusion high-dose human lymphoblastoid Interferon and the in vitro sensitivity of leukemia progenitors in

nonlymphocytic leukemia. Cancer Treat. Rep. 70:363-67, 1986.

57. Williams, D.L., Harber, J., Murphy, S.B., Look, A.T., Kalwinsky, D.K., Rivera, G., Melvin, S.L., Stass, S., and Dahl, G.V.:

Chromosomal translocations play a unique role in influencing prognosis in childhood acute lymphoblastic leukemia.

Blood 68:205- 212, 1986.

58. Bunin, N.J., Hvizdala, E., Link, M., Callihan, T.R., Hustu, H.O., Wharam, M., Warnke, R.A., Berard C.W., and Murphy,

S.B.: Mediastinal nonlymphoblastic lymphomas in children: A clinicopathologic study. J. Clin. Oncol. 4:154-159, 1986.

59. Raimondi, S.C., Williams, D.L., Callihan, T., Peiper, S., Rivera, G.K., and Murphy, S.B.: Nonrandom involvement of the

12p12 breakpoint in chromosome abnormalities of childhood acute lymphoblastic leukemia. Blood 68:6975, 1986.

60. Ochs, J., Abromowitch, M., Rudnick, S., and Murphy, S.B.: Phase I-II study of recombinant alpha-2 Interferon against

advanced leukemia and lymphoma in children. J. Clin. Oncol. 4:883-887, 1986.

61. Pui, C-H., Williams, D.L., Kalwinsky, D.K., Look, A.T., Melvin, S.L., Dodge, R.K., Rivera, G., Murphy, S.B., and Dahl,

G.V.: Cytogenetic features and serum lactic dehydrogenase level predict a poor treatment outcome for children with

pre-B-cell leukemia. Blood 67:1688-1692, 1986.

62. Mirro, J., Kitchingman, G.R., Zipf, T.F., Williams, D.L., Murphy, S.B., and Stass, S.: Mixed lineage leukemia: The

implications for hematopoietic differentiation. (Letter to the Editor). Blood. 68:597-598, 1986.

63. Rivera, G.K., George, S.L., Williams, D., Look, A.T., Abromowitch, M., Pui, C-H., Ochs, J.J., Dahl, G.V., Kalwinsky,

D.K., Mirro, J., Dow, L.W., Raimondi, S., and Murphy, S.B.: Early results of intensified remission induction

chemotherapy for childhood acute lymphocytic leukemia. Med. Ped. Oncol. 14:177-181, 1986.

64. Murphy, S.B., Bowman, W.P., Abromowitch, M., Mirro, J., Ochs, J., Rivera, G., Pui, C-H., Fairclough, D., and Berard,

C.W.: Results of treatment of advanced stage Burkitt's lymphoma and B-cell (SIg+) acute lymphoblastic leukemia with

of 32

high-dose fractionated cyclophosphamide and coordinated high dose methotrexate and cytarabine. J. Clin. Oncol.

4:1732-1739, 1986.

65. Pui, C-H., Williams, D.L., Raimondi, S., Melvin, S.L., Behm, F.G., Look, A.T., Dahl, G.V., Rivera, G.K., Kalwinsky, D.K.,

Mirro, J., Dodge, R.K., and Murphy, S.B.: Unfavorable presenting clinical and laboratory features are associated with

CALLA-negative non-T, non-B lymphoblastic leukemia in children. Leuk. Res. 10:1287-1292, 1986.

66. Weiss, K., Stass, S., Williams, D., Kalwinsky, D., Dahl, G.V., Wang, W., Johnson, F.L., Murphy, S.B., and Dow, L.W.:

Childhood monosomy 7 syndrome: Clinical and in vitro studies. Leukemia 1:97-104, 1987.

67. Griffith, R.C., Kelly, D.R., Nathwani, B.N., Shuster, J.J., Murphy, S.B., Hvizdala, E., Sullivan, M.P., and Berard, C.W.: A

morphologic study of childhood lymphoma of the lymphoblastic type: the Pediatric Oncology Group experience. Cancer

59:1126-1131, 1987.

68. Kelly, D.R., Nathwani, B.N., Griffith, R.C., Shuster, J.J., Sullivan, M.P., Hvizdala, E., Murphy, S.B., and Berard, C.W.: A

morphologic study of childhood lymphoma of the undifferentiated type: the Pediatric Oncology Group experience.

Cancer 59:1132-1137, 1987.

69. Nathwani, B.N., Griffith, R.C., Kelly, D.R., Shuster, J.J., Hvizdala, E., Sullivan, M.P., Murphy, S.B., and Berard, C.W.: A

morphologic study of childhood lymphoma of the diffuse "histiocytic" type: the Pediatric Oncology Group experience.

Cancer 59:1138-1142, 1987.

70. Mirro, J., Kitchingman, G., Behm, F.G., Murphy, S.B., and Goorha, R.M.: T-cell differentiation stages identified by

molecular and immunologic analysis of the T-cell receptor complex in childhood lymphoblastic leukemia. Blood

69:908-912, 1987.

71. Pui, C-H., Raimondi, S.C., Murphy, S.B., Ribeiro, R.C., Kalwinsky, D.K., Dahl, G.V., Crist, W.M., and Williams, D.L.:

An analysis of leukemic cell chromosomal features in infants. Blood 69:1289-1293, 1987.

72. Dahl, G.V., Rivera, G.K., Look, A.T., Hustu, O., Kalwinsky, D.K., Abromowitch, M., Mirro, J., Ochs, J., Murphy, S.B.,

Dodge, R.K., and Pui, C-H.: Teniposide plus cytarabine improves prognosis in childhood acute lymphoblastic leukemia

presenting with a leukocyte count >100 x 109/L. J. Clin. Oncol. 5:1015-1021, 1987.

73. Goorha, R., Bunin, N., Mirro, J., Murphy, S.B., Cross, A.H., Behm, F.G., Quertermous, T., Seidman, J., and

Kitchingman, G.R.: Provocative pattern of rearrangements of the genes for the gamma- and beta-chains of the T-cell

receptor in human leukemias. PNAS 84:4547-4551, 1987.

74. Rivera, G.K., and Murphy, S.B.: Cure of acute lymphocytic leukemia following relapse. (Letter to the Editor) Pediatrics

79:650, 1987.

75. Pui, C-H., Behm, F.G., Kalwinsky, D.K., Murphy, S.B., Butler, D.L., Dahl, G.V., and Mirro, J.: Clinical significance of

low levels of myeloperoxidase positivity in childhood acute nonlymphoblastic leukemia. Blood 70:51-54, 1987.

76. Pui, C-H., Williams, D.L., Raimondi, S.C., Rivera, G.K., Look, A.T., Dodge, R.K., Behm, F.G., Crist, W.M., and Murphy,

S.B.: Hypodiploidy is associated with a poor prognosis in childhood acute lymphoblastic leukemia. Blood 70:247-253,

1987.

77. Raimondi, S.C., Murphy, S.B., Williams, D.L.: Newly defined clusters of translocations in childhood acute lymphoblastic

leukemia. Ninth International Workshop on Human Gene Mapping. Cytogenet Cell Genet 46:679, 1987.

78. Pui, C-H., Ip, S.H., Kung, P., Dodge, R.K., Berard, C.W., Crist, W.M., and Murphy, S.B.: High serum interleukin-2

receptor levels are related to advanced disease and a poor outcome in childhood non-Hodgkin's lymphoma. Blood

70:624-628, 1987.

79. Ribeiro, R.C., Abromowitch, M., Raimondi, S.C., Murphy, S.B., Behm, F., and Williams, D.L.: Clinical and biologic

hallmarks of the Philadelphia chromosome in childhood acute lymphoblastic leukemia. Blood 70:948-953, 1987.

80. Murphy, S.B., Mirro, J., Pui, C-H., and Pratt, C.B.: Phase I-II trial of N-methyl-formamide (NMF, NSC-3051) in

of 32

pediatric patients with refractory leukemias. Cancer Treat. Reps. 71:1299-1300, 1987.

81. Look, A.T., Roberson, P.K., and Murphy, S.B.: The prognostic value of cellular DNA content in acute lymphoblastic

leukemia. (Letter) N. Engl. J. Med. 317:1666, 1987.

82. Pui, C-H., Williams, D.L., Roberson, P.K., Raimondi, S.C., Behm, F.G., Lewis, S.S., Rivera, G.K., Kalwinsky, D.K.,

Abromowitch, M., Crist, W.M., and Murphy, S.B.: Correlation of karyotype and immunophenotype in childhood acute

lymphoblastic leukemia. J. Clin. Oncol. 6:56-61, 1988.

83. Abromowitch, M., Ochs, J., Pui, C-H., Fairclough, D., Murphy, S.B., and Rivera, G.K.: Efficacy of high-dose

methotrexate in childhood acute lymphocytic leukemia: analysis by contemporary risk classifications. Blood 71:866-869,

1988.

84. Pui, C-H., Ip, S.H., Iflah, S., Behm, F.G., Grose, B.H., Dodge, R.K., Crist, W.M., Furman, W.L., Murphy, S.B., and

Rivera, G.K.: Serum interleukin-2 receptor levels in childhood acute lymphoblastic leukemia. Blood 71:1135-1137,

1988.

85. Pui, C-H., Dodge, R.K., Berard, C.W., Crist, W.M., Murphy, S.B., Ip, S.H., Kung, P.: Soluble interleukin-2 receptor in

childhood non-Hodgkin's lymphoma. (Letter) Blood, 71:1174, 1988.

86. Stapleton, F.B., Strother, D.R., Roy, A., Wyatt, R.J., McKay, C.P., and Murphy, S.B.: Acute renal failure at onset of

therapy for advanced stage Burkitt lymphoma and B-cell (SIg+) acute lymphoblastic leukemia. Pediatrics 82:863-869,

1988.

87. Abromowitch, M., Ochs, J., Pui, C-H., Kalwinsky, D.K., Rivera, G.K., Fairclough, D., Look, A.T., Hustu, O., Murphy,

S.B., Evans, W.E., Dahl, G.V., and Bowman, W.P.: High-dose methotrexate improves clinical outcome in children with

acute lymphoblastic leukemia: St. Jude Total Therapy Study X. Med. Pediatr. Oncol. 16:297-303, 1988.

88. Nuss, R., Ribeiro, R.C., Bunin, N., Behm, F., Jenkins, J., Berard, C., and Murphy, S.B.: Immunoblastic peripheral T-cell

lymphoma confined to bone marrow in an infant presenting with aspergillosis. Med. Pediatr. Oncol. 16:220-223, 1988.

89. Winick, N., Buchanan, G.R., Murphy, S.B., and Yu, A.: Deoxycoformycin treatment for childhood T-cell acute

lymphoblastic leukemia early in second remission: A Pediatric Oncology Group Study. Med. Pediatr. Oncol. 16:327-332,

1988.

90. Hutchison, R.E., Pui, C-H., Murphy, S.B., and Berard, C.W.: Non-Hodgkin's lymphoma in children less than three years

of age. Cancer 62:1371-73, 1988.

91. Pui, C-H., Ip, S., Dodge, R.K., Carrabis, S., Brown, M., Crist, W.M., Berard, C.W., Kung, P., Dahl, G.V., and Murphy,

S.B.: Serum levels of CD8 antigen in childhood lymphoid malignancies: a possible indicator of increased suppressor cell

activity in poor risk patients. Blood 72:1015-1021, 1988.

92. Pui, C-H., de Graaf, S.S.N., Dow, L.W., Rodman, J.H., Evans, W.E., Alpert, B.S., and Murphy, S.B.: Phase 1 clinical trial

of orally administered 4-demethoxydaunorubicin (idarubicin) with pharmacokinetic and in-vitro drug-sensitivity testing

in children with refractory leukemia. Cancer Res. 48:5348-5352, 1988.

93. Murphy, S.B.: L1 morphology of acute B lymphocytic leukemia in children. (Letter). Leukemia 2:474, 1988.

94. Murphy, S.B.: AIDS-associated lymphoma of the brain in a child. (Letter). Pediatrics 82:678, 1988.

95. Raimondi, S.C., Behm, F.G., Roberson, P.K., Pui, C-H., Rivera, G.K., Murphy, S.B., and Williams, D.L.: The

cytogenetics of childhood T-cell leukemia. Blood 72:1560-1566, 1988.

96. Cross, A., Goorha, R., Nuss, R., Behm, F., Murphy, S.B., Kalwinsky, D., Kitchingman, G., and Mirro, J.: Acute myeloid

leukemia with T-lymphoid features: A distinct clinical and biologic entity. Blood 72:579-587, 1988.

97. Pui, C-H., Raskind, W., Kitchingman, G.R., Raimondi, S., Behm, F. G., Murphy, S.B., Crist, W.M., Fialkow, P.J. and

Williams, D.G.: Clonal analysis of childhood acute lymphoblastic leukemia with "cytogenetically independent" cell

of 32

populations. J. Clin. Invest. 83:1971-77, 1989.

98. Ault, B.H., Stapleton, F.B., Gaber, L., Martin, A., Roy, S., III, Murphy, S.B.: Acute renal failure associated with

recombinant human gamma interferon therapy. N. Eng. J. Med. 319:1397-1400, 1989.

99. Patton, D.F., Sixbey, J.W., and Murphy, S.B.: EBV in human immunodeficiency virus-related Burkitt lymphoma. (Letter).

J. Peds. 113:951, 1988.

100. Murphy, S.B., Fairclough, D.L., Hutchison, R.E., and Berard, C.W.: Non-Hodgkin's lymphomas of childhood: Analysis of

the histology, staging and response to treatment of 338 cases at a single institution. J. Clin. Oncol. 7:186-193, 1989.

101. Pui, C-H., Behm, F., Raimondi, S., Dodge, R.K., George, S.C., Rivera, G.K., Mirro, J., Kalwinsky, D., Dahl, G.V.,

Murphy, S.B., Crist, W.M., and Williams, D.L.: Secondary acute myeloid leukemia in children treated for acute lymphoid

leukemia. New Engl. J. Med. 321:136-142, 1989.

102. Murphy, S.B., Raimondi, S.C., Rivera, G.K., Crone, M., Dodge, R.K., Behm, F.G., Pui, C-H., and Williams, D.L.:

Nonrandom abnormalities of chromosome 9p in childhood acute lymphoblastic leukemia. Association with high-risk

clinical features. Blood 74:409-415, 1989.

103. Murphy, S.B., Fairclough, D.F., Hutchison, R.E., and Berard, C.W.: Prognostic subgroups in childhood non-Hodgkin's

lymphoma (Letter to the Editor) J. Clin. Oncol. 7:1174-1177, 1989.

104. Mirro, J.M., Kalwinsky, D., Grier, H.E., Santana, V.M., Mason, C., Murphy, S.B., and Dahl, G.V.: Simultaneous

continuous infusions of teniposide and amacrine: effective reinduction therapy for acute nonlymphoid leukemia. Cancer

Chemotherapy and Pharmacology 24:123-27, 1989.

105. Furman, W.L., Fitch, S., Hustu, H.O., Callihan, T., Murphy, S.B.: Primary lymphoma of bone in children. J. Clin. Oncol.

7:1275-80, 1989.

106. Hutchison, R.E., Murphy, S.B., Fairclough, D.L., Shuster, J.J., Sullivan, M.P., Link, M.P., Donaldson, S.S., and Berard,

C.W.: Diffuse small noncleaved-cell lymphoma in children, Burkitt's versus Non-Burkitt's types: Results from the

Pediatric Oncology Group and St. Jude Children's Research Hospital. Cancer 64:23-28, 1989.

107. Strother, D.R., Glynn-Barnhart, A., Kovnar, E., Gregory, R.E., and Murphy, S.B.: Variability in the disposition of

intraventricular methotrexate: a proposal for rational dosing. J. Clin. Oncol. 7:1741-47,1989.

108. Kellie, S.J., Pui, C-H., Murphy, S.B.: Childhood non-Hodgkin's lymphoma involving the testis: clinical features and

treatment outcome. J. Clin. Oncol. 7:1066-77, 1989.

109. Dahl, G.V., Kalwinsky, D.K., Mirro, Jr., J., Look, A.T., Pui, C-H., Murphy, S.B., Mason, C., Ruggierio, M., Schell, M.,

Johnson, F.L., and Thomas, E.D.: Allogeneic bone marrow transplantation in a program of intensive sequential

chemotherapy for children and young adults with acute non-lymphocytic leukemia in first remission. J. Clin. Oncol.

8:295-303, 1990.

110. Link, M.P., Donaldson, S.S., Berard, C.W., Shuster, J.J., and Murphy, S.B.: End results of treating childhood localized

non-Hodgkin's lymphoma with combination chemotherapy with or without radiotherapy. NEJM, 322:1169-1174, 1990.

111. Fleming, I.D., Turk, P.S., Murphy, S.B., Crist, W.M., Santana, V.M., and Rao, B.N.: Surgical implications of primary

gastrointestinal lymphoma of childhood: AMA Archives of Surgery, 125:252-256, 1990.

112. Chadwick, E.G., Connor, E.J., Guerra Hanson, I.C., Joshi, V.V., Abu-Farsakh, H., Yogev, R., McSherry, G., McClain, K.,

and Murphy, S.B.: Tumors of smooth muscle origin in HIV-infected children. JAMA, 263:3182-3184, 1990.

113. Sullivan, M.P., Pullen, D.J., Cooper, M.D., Crist, W.M., Brecher, M., Ramirez, I., Sabio, H., Borowitz, M.J., Head, D.R.,

Cerezo, L., Shuster, J.J., and Murphy, S.B.: Clinical and biological heterogeneity of childhood B-cell leukemia:

implications for clinical trials. Leukemia 4:6-11, 1990.

114. Rivera, G.K., Raimondi, S.C., Hancock, M.L., Behm, G.F., Pui, C-H, Abromowitch, M., Mirro, Jr., J., Ochs, J.S., Look,

of 32

A.T., Williams, D.L., Murphy, S.B., Dahl, G.V., Kalwinsky, D.K., Evans, W.E., Kun, L.E., Simone, J.V., and Crist, W.M.:

Improved outcome in childhood acute lymphoblastic leukemia with reinforced early treatment and rotational combination

therapy. The Lancet 337:61-66, 1991.

115. Mahmoud, H.H., Wang, W.C., and Murphy, S.B.: Cyclosporine therapy for advanced Langerhans cell histiocytosis.

Blood 77:721-725, 1991.

116. Mahmoud, H., Gaber, O., Wang, W., Whitington, G., Vera, S., and Murphy, S.B.: Successful orthotopic liver

transplantation in a child with Langerhans cell histiocytosis. Transplantation 51:278-280, 1991.

117. Pediatric Oncology Group: Vietti, T.J., Shuster, J.J., Amylon, M., Berard, C., Borowitz, M., Bowman W.P., Brecher, M.,

Castleberry, R., Frankel, L., Goorin, A., Hayes, F.A., Hvizdala, E., Krischer, J.P., Land, V., Link, M., McWilliams, N.,

Murphy, S., Pick, T., Pullen, J., Ravindranath, Y., Smith, E.I., Steuber, C.P., Sullivan, M., van Eys, J., Wharam, M., Crist,

W. Progress against childhood cancer: The Pediatric Oncology Group Experience. Pediatrics, 89: 597-600, 1992.

118. Ribeiro, R.C., Pui, C.H., Murphy, S.B., Shuster, J.J., Hvizdala, E.V., Falletta, J., Link, M.P., Sullivan, M.P., Pick, T.E.,

Sandlund, J.T., Fairclough, D., Crist, W.M., and Berard. C.W. Childhood Malignant Non-Hodgkin's Lymphomas of

Uncommon Histology. Leukemia, 6:761-765, 1992.

119. Mahmoud, H.H., Pui, C.-H., Kennedy, W., Jaffe, H.S., Crist, W.M., and Murphy, S.B.: Phase I Study of Recombinant

Human Interferon Gamma in Children with Relapsed Acute Leukemia. Leukemia, 6:1181-1184, 1992.

120. Hsueh, C., Gonzalez-Crussi, F., and Murphy, SB, Testicular Angiocentric Lymphoma of Post-Thymic T-Cell Type in a

Child With T-Cell Acute Lymphoblastic Leukemia in Remission, Cancer, 72:1801-5, 1993.

121. Bernstein, M.L., Whitehead, V.M., Grier, H., Dubowy, R., Land, V., Devine, S., Murphy, S., and Kung, F. A Phase I Trial

of Fazarabine in Refractory Pediatric Solid Tumors. Investigational New Drugs, 11:309-312, 1993.

122. Sioutos, N., Kerl, H., Murphy, S.B., Kadin M.E.,: Primary Cutaneous Hodgkin's Disease: Unique Clinical, Morphologic

and Immunophenotypic Findings. Am J. Dermatopathology, 16:2-8, 1994.

123. McClain, K.L., Leach, C.T., Jenson, H.B., Joshi, V.V., Pollock, B.H., Parmley, R.T., DiCarlo, F.J., Chadwick, E.G., and

Murphy, S.B.: Association of Epstein-Barr Virus with Leiomyosarcomas of Children with AIDS. New Engl. J. Med.,

332:12-18, 1995.

124. Kung FH, Desai S.J., Dickerman J., Goorin A.M., Harris M.B., Inoue S., Krischer J.P., Murphy S.B., Pratt C.B.,

Toledano S., Wiley J.M., and Yu, A.L. Ifosfamide/Carboplatin/Etoposide (ICE) for Recurrent Malignant Solid Tumors of

Childhood. A Pediatric Oncology Group Phase I/II Study. J Ped Hem/Onc, 17:265-269, 1995.

125. Martinez-Climent, J.A., Lane, N.J., Rubin, C.M., Morgan, E., Johnstone, H.S., Mick R., Murphy, S.B., Vardiman, J.W.,

Larson, R.A., LeBeau, M.M., Rowley, J.D. Clinical and Prognostic Significance of Chromosomal Abnormalities in

Childhood Acute Myeloid Leukemia De Novo. Leukemia, 9:95-101, 1995.

126. Hutchison, R.E., Berard, C. W., Shuster, J.J., Link, M.P., Pick, T.E., Murphy, S.B. B-cell Lineage Confers a Favorable

Outcome Among Children and Adolescents with Large Cell Lymphoma: A Pediatric Oncology Group Study. J Clin Onc,

13:2023-2032 1995.

127. Smith, M., Arthur, D., Camitta, B., Carroll, A.J., Crist, W., Gaynon, P., Gelber, R., Heerema, N., Korn, E., Link, M.,

Murphy, S.B., Pui, C.H., Pullen, J., Reaman, G., Sallan, S.E., Sather, H., Shuster, J., Simon, R., Trigg, M., Tubergen, D.,

Uckun, F., Ungerleider, R.. A Uniform Approach To Risk-Classification And Treatment Assignment For Children With

Acute Lymphoblastic Leukemia. J. Clin. Oncol. 14:18-24, 1996

128. Bowman, W.P., Shuster, J.J., Cook, B., Griffin, T. Behm, F., Pullen, J., Link, M., Head, D., Carroll, A., Berard, C.,

Murphy,S.B., Improved Survival for Children with B Cell Acute Lymphoblastic Leukemia and Stage IV Small Noncleaved

Cell Lymphoma: A Pediatric Oncology Group Study. J. Clin. Oncol, 14:1252-1261, 1996

129. Jenson, H., Leach, C., Montalvo, E., Chung-Lin, J., Murphy, S. B. Absence of Herpesvirus in AIDS-Associated Smooth-

Muscle Tumors (Letter). New England Journal of Medicine, 335:1690, 1996.

of 32

130. Hutchison, R.E., Banki, K., Shuster, J.J., Barrett D., Dieck, C., Berard, C.W., Murphy, S.B., Link, M.P., Pick, T.E.,

LaverJ., Schwenn, M., Mathew, P., Morris, S.W. Use of An Anti-Alk Antibody In The Characterization of Anaplastic

Large Cell Lymphoma of Childhood. Ann. Oncol. 8 (Suppl. 1): S37-S42, 1997.

131. Dowd, D.M., Morgan, E.R., Langman, C.B., Murphy, S.B. Serum Erythropoietin Levels In Children With Leukemia.

Medical and Pediatric Oncology, 28:259-267, 1997.

132. Joshi, V.V., Gagnon, G.A., Chadwick, E.G., Berard, C.W., McClain, K.L., Leach, C.T., Jenson, H.B., Murphy, S.B.. The

Spectrum of Mucosa-Associated Lymphoid Tissue (MALT) Lesions In Pediatric Patients Infected With The Human

Immunodeficiency Virus (HIV): A Clinicopathologic Study Of Six Cases: Am. J. Clin. Pathol, 107:592-600, 1997.

133. Murphy,S.B.: Cyclosporine in Activated Macrophage and Histiocytic Syndrome.(Letter to the Editor)

J.Peds,130:1012,1997.

134. Jenson, H., Leach, C., McClain, K., Joshi, V., Pollock, B., Parmley, R., Chadwick, E., Murphy, S.B. Benign and

malignant smooth muscle tumors containing Epstein-Barr virus in children with AIDS. Leukemia and Lymphoma,

27:303-14,1997

135. Bleyer, A., Tejeda, H., Murphy, S.B., Brawley, O., Smith, M., Ungerleider, R.. National Pediatric Cancer Clinical Trials:

Children Have Equal Access; Adolescents Do Not. J. Adolescent Health., 21:366-73,1997.

136. Bleyer, A., Murphy, S.B., Tejeda, H.A., Brawley, O.W., Smith, M.A., Ungerleider, R.S. Equal Participation of Minority

Patients in U.S. National Pediatric Cancer Clinical Trials. J. Ped. Hem/Onc.19:423-427,1997

137. Karayalcin, G., Behm, F., Gieser, P., Kung, F., Weiner, M., Tebbi, C., Ferree, C., Marcus, R., Constine, L., Mendenhall,

N., Chauvenet, A., Murphy, S.B.. Lymphocyte Predominant Hodgkin’s Disease: Clinico-pathologic features and results

of treatment. The Pediatric Oncology Group Experience. Med. Ped. Oncol. 29:519-525, 1997

138. Link, M., Shuster, J., Donaldson, S., Berard, C., Murphy, S.B. Treatment of Children and Young Adults with Early Stage

Non-Hodgkin’s Lymphoma. New Engl.J. Med.337:1259-66, 1997

139. Brecher, M.L., Schwenn, M.R., Coppes, M.J., Bowman, W.P., Link, M.P., Berard, C.W., Shuster, J.J., Murphy, S.B.

Fractionated Cyclophosphamide and Back to Back High Dose Methotrexate and Cytosine Arabinoside Improves

Outcome in Patients with Stage III High Grade Small Non-Cleaved Cell Lymphomas (SNCCL): A Randomized Trial of

the Pediatric Oncology Group. Medical and Pediatric Oncology 29:526-533, 1997.

140. Koller, C.A., Kantarjian, H.M., Thomas, D., O’Brien, S., Rios, M.B., Kornblau, S. Murphy, S.B. and Keating, M. The

Hyper-CVAD Regimen Improves Outcome in Relapsed Acute Lymphoblastic Leukemia. Leukemia 11:2039-2044, 1997.

141. Leach, C.T., Frantz, C., Head, D.R., McClain, K.L., Cohen, M., Campbell, A.B., Pollock, B.H., Murphy, S.B. and Jenson,

H.B. Human herpesvirus-8 (HHV-8) associated with small non-cleaved cell lymphoma in a child with AIDS. Am.J.

Hemat.60:215-221,1999.

142 Suryanarayan, K., Shuster, J.J., Donaldson, S.S., Hutchison, Robert E., Murphy, S.B., Link, M.P. Treatment of Localized

Primary Non-Hodgkin’s Lymphoma of Bone in Children. J.Clin.Oncol.17:456-459,1999.

143. Amylon, M., Shuster, J., Pullen, J., Berard, C., Link, M., Wharam, M., Katz, J., Yu, A., Laver, J., Ravindranath, Y.,

Kurtzberg, J., Desai, S., Camitta, Murphy, S. Intensive High Dose Asparaginase Consolidation Improves Survival For

Pediatric Patients With T-Cell Acute Lymphoblastic Leukemia And Advanced Stage Lymphoblastic Lymphoma: A

Pediatric Oncology Group Study 8704, Leukemia 13:335-342, 1999.

144. Thomas, D., Cortes, J., O’Brien, S., Pierce, S., Faderl, S., Albitar, M.,Hagemeister, F.B., Cabanillas, F.F., Murphy, S.B.,

Keating, M.J., Kantarjian, H. The Hyper-CVAD Program in Burkitt’s-Type Adult Acute Lymphoblastic Leukemia. J.

Clin. Oncol.17: 2461-2470, 1999

of 32

145. Kantarjian, HM, O’Brien, S., Smith, T.L., Cortes, J., Giles, F.J., Beran, M., Pierce, S., Huh, Y., Andreeff, M., Koller, C.,

Ha, C., Keating, M., Murphy, S., and Freireich, E.J. Results of Treatment with Hyper-CVAD, a Dose-Intensive Regimen,

in Adult Acute Lymphocytic Leukemia. J. Clin. Oncol. 18:547-561, 2000.

146. Pollock, B.H., DeBaun, M., Camitta, B., Shuster, J.J., Ravindranath, Y., Pullen, D. J., Land, V. Mahoney, Jr., D.H.,

Lauer, S.J., and Murphy, S.B., Racial Differences in the Survival of Childhood B-Precursor Acute Lymphoblastic

Leukemia: A Pediatric Oncology Group Study. J. Clin. Oncol.18:813-823, 2000.

147. Hutchison,R.E., Finch, C., Kepner, J.. Fuller, C., Bowman, P., Link, M., Schwenn, M., Laver, J., Desai, S., Barrett, D.,

Murphy, S.B. Burkitt Lymphoma Is Immunophenotypically Different from Burkitt-like Lymphoma in Young Persons.

Annals of Oncology, 11(Suppl1):535-538, 2000

148. McClain, K.L., Leach, C.T., Jenson, H.B., Joshi, V.V., Pollock, B.H., Berard, C.W., Murphy, S.B. Molecular and

Virologic Characteristics of Lymphoid Malignancies in Children with AIDS. JAIDS, Journal of Acquired Immune

Deficiency Syndromes, 23:152-159, 2000

149 Griffin, T.C., Shuster, J.J., Buchanan, G.R., Murphy, S.B., Camitta, B.M., Amylon, M.D. Slow Disappearance of

Peripheral blood blasts Is An Adverse Prognostic Factor in Childhood T-Cell Acute Lymphoblastic Leukemia: A

Pediatric Oncology Group Study, Leukemia, 14:792-795, 2000

150 Laver, J.H., Barredo, J.C., Amylon, M., Schwenn, M., Kurtzberg, J., Camitta, B.M., Pullen, J., Link, M., Borowitz M.,

Ravindranath Y., Murphy, S.B., Shuster, J. Effects of Cranial Radiation in Children with High Risk T-Cell Acute

Lymphoblastic Leukemia: A Pediatric Oncology Group Report; Leukemia 14:369-373. 2000

151. Sandlund, J.T., Murphy, S.B., Santana, V.M., Behm, F.,Jones, D., Berard, C.W., Furman, W.L., Ribeiro, R., Crist, W.M.,

Greenwald, C., Chen, G., Walter, A., Pui, C.H., Central Nervous System Involvement in Children with Newly Diagnosed

Non-Hodgkin Lymphoma. J. Clin. Oncol, 18:3018-3024, 2000

152. Maloney, KW., Shuster, J.J., Murphy, S.B., Pullen, J., Camitta, B.A. Long Term Results of Treatment Studies for

Childhood Acute Lymphoblastic Leukemia: Pediatric Oncology Group Studies from 1986-1994, Leukemia 14:2276-85,

2000

153. Shaw, P.H., Cohn, S.L., Morgan, E.R., Kovarik, P., Haut, P.R., Kletzel, M., Murphy, S.B. Naural Killer Cell Lymphoma:

Report of Two Pediatric Cases, Therapeutic Options and Review of the Literature, Cancer 91:642-6, 2001

154. Shochat, S.J., Fremgen, A.M., Murphy, S.B, Hutchison, C., Donaldson, S.S., Haase, G.M., Provisor, A.J., Clive, R.E.,

Winchester, D.P.Childhood Cancer: Patterns of Protocol Participation in a National Survey, Ca, a Journal for Clinicians

51:119-130, 2001

155. Laver, J., Mahmoud, H., Pick, T.E., Weinstein, H.J., Schwenn, M., Weitzman, S., Murphy, S.B., Ochoa, S., Shuster, J.J.

Results of a Randomized Phase III Trial in Children and Adolescents with Advanced Stage Diffuse Large Cell Non

Hodgkin’s Lymphoma: A Pediatric Oncology Group Study, Leukemia and Lymphoma, 43:105-109,2002

156. Leach, C.,T., Pollock, B.H., McClain, K.L., Parmley, R.T., Murphy, S.B., Jenson, H.B. Human Herpesvirus 6 (HHV-6)

and Cytomegalovirus (CMV) Infections in Children with Acquired Immunodeficiency Syndrome (AIDS) and Cancer.

Pediatric Infectious Dis. J., 21:125-32, 2002

157. Pollock, B.H., Jenson, H.B., Leach, C.T., McClain, K.L., Hutchison, R.E., Garzarella, L., Joshi, V.V., Parmley, R.T.,

Murphy, S.B. Risk Factors for Pediatric Human Immunodeficiency Virus (HIV)-Related Malignancy. JAMA, 28: 2393-

2399, 2003

158. Murphy, S.B., Morgan, E.R., Katzenstein, Kletzel, M. Results of Little or No Treatment for Lymphocyte Predominant

Hodgkin’s Disease in Children and Adolescents, J. Peds Hem Onc. 25:684-687, 2003

159. Shani-Adir, A., Lucky, A.W., Prendiville, J., Murphy, S.B., Passo, M.H., Huang, F.S., Paller, A.S. Subcutaneous

Panniculitic T-Cell Lymphoma in Children: Dramatic Improvement with Cyclosporine Administration, J. Am.Acad.

Dermatology. 50:S18-22, 2004.

of 32

160. Laver, J.H., Kraveka, J., Hutchinson, R.E., Chang, Y., Kepner, J., Schwenn, M., Tarbell, N., Desai, S., Weitzman, S.,

Weinstein, H.J., Murphy, S.B. Advanced Stage Large Cell Lymphoma in Children and Adolescents: Results of a

Randomized Phase III Pediatric Oncology Group Trial. J. Clin. Oncol. 23:541-547, 2005.

161. Appelbaum, F.R., Rosenblum, D., Arceci, R.J., Carroll, W, Breitfeld, P.D., Forman, S.J., Larson, R.A., Lee, S.J., Murphy,

S.B., O’Brien, S., Pazdur, R., Radich, J., Scher, N.S., Smith, F.O., Stone, R. Endpoints to Establish the Efficacy of New

Agents in the Treatment of Acute Leukemia. Blood 109:1810-1816, 2007.

162. Hutchison, R.E., Laver, J.H., Chang, M., Muzzafar, T., Desai, S., Murphy, S., Schwenn, J., Shuster, J., and Link, M.P.

Non-Anaplastic Peripheral T-Cell Lymphoma in Childhood and Adolescence: A Children’s Oncology Group Study.

Pediatric Blood and Cancer, 51:29-33, 2008.

163. Abernethy A., Etheredge L.M., Ganz P., Wallace P., German R.., Neti C., Bach P., and Murphy S.B. A Rapid Learning

System for Cancer Care, J Clin Oncol, 28:4268-4274, 2010

163. Hirsch,B, Giffin R, Esmail L, Tunis S, Abernethy A, and Murphy SB. Informatics in action: Lessons learned in

comparative effectiveness research, The Cancer Journal: the Journal of the Principles and Practice of Oncology, 17:

235-238, 2011

164. Balogh E, Ganz P, Murphy SB, Nass SJ, Ferrell B, and Stovall E. Patient-Centered Cancer Treatment Planning:

Improving the Quality of Oncology Care. , The Oncologist, 16:1800-1805, 2011

Chapters, Reviews, Books

1. Murphy, S. and Davis, L.: Hodgkin's disease and the non-Hodgkin's lymphomas in childhood. Semin. Oncol. 1:17,

1974.

2. Mauer, A.M. and Murphy, S.B.: Growth regulation of human acute leukemia cell populations. In, A.A. Gottlieb, O.J.

Plescia, and D. Bishop, (eds), Fundamental Aspects of Neoplasia, pp. 389-399, Springer-Verlag, New York, 1975.

3. Murphy, S.B. and Mauer, A.M.: Staging of acute lymphoblastic leukemia. Conflicts in Childhood Cancer, In, L. Sinks,

J. Godden, eds). Progress in Clinical and Biological Research, Vol. 4:7-29, A. Liss, Inc., 1975.

4. Mauer, A.M. and Murphy, S.B.: Cell kinetics and practical consequences for therapy of acute leukemia. Proc. Inst.

Med. Chicago 30:247, 1975.

5. Murphy, S.B.: Non-Hodgkin's lymphoma of childhood. In, M. Donaldson, H.G. Seydel, (eds)., Trends in Childhood

Cancer, pp. 31-36, Wiley and Sons, 1976.

6. Murphy, S.B., Dahl, G.V., Rivera, G., and Mauer, A.M.: Pilot cell kinetic observations on the combination of

methotrexate and cytosine arabinoside in childhood acute lymphoblastic leukemia in relapse. In, J. Schumann, W.

Gohde, and T. Buchner, (eds), Second International Symposium on Pulse Cytophotometry, pp. 418-426, European Press,

Ghent, Belgium, 1976.

7. Mauer, A.M., Murphy, S.B. and Hayes, F.M.: Evidence for recruitment and synchronization in leukemia and solid

tumors. Cancer Treat. Rep. 60:1841-1844, 1976.

8. Mauer, A.M., Murphy, S.B., Hayes, F.A., and Dahl, G.V.: Scheduling and recruitment in malignant cell populations. In,

B. Drewinko and R. Humphrey eds), Growth Kinetics and Biochemical Regulation of Normal and Malignant Cells, pp.

855-864, The Williams and Wilkins Co., Baltimore, 1977.

9. Murphy, S.B.: The management of childhood non-Hodgkin's lymphoma. Cancer Treat. Rep. 61:1161-1173, 1977.

10. Murphy, S.B. and Ransom, J.L.: Histiocytosis X. In, Volume III, Chapter 80, pp. 1-13, Practice of Pediatrics, Harper

of 32

and Row, Hagerstown, Maryland, 1977.

11. Murphy, S.B. and Thompson, E.: The Lymphomas. In, Volume III, Chapter 79, pp. 1-16, Practice of Pediatrics, Harper

and Row, Hagerstown, Maryland, 1977.

12. Murphy, S.B.: Prognostic features and obstacles to cure of childhood non-Hodgkin's lymphoma. Semin. Oncol.

4:265-271, 1977.

13. Murphy, S.B. and Mauer, A.M.: Terminal transferase and lymphoblastic malignancies. N. Engl. J. Med. 297:502-503,

1977.

14. Murphy, S.B. and Mauer, A.M.: Blast cell kinetic studies in children with acute leukemia and diffuse non-Hodgkin's

lymphomas: Prognostic and Therapeutic Implications. In, D. Lutz, (ed), Third International Symposium on Pulse

Cytophotometry, pp. 669-674. European Press, Ghent, Belgium, 1978.

15. Murphy, S.B.: Current concepts: Childhood non-Hodgkin's lymphoma. N. Engl. J. Med., 299:1446-1448, 1978.

16. Murphy, S.B.: Combined modality therapy of childhood non-Hodgkin's lymphoma. Lymphoid Neoplasias II: Clinical

and Therapeutic Aspects. In, Mathe, G., Seligmann, M., Tubiana, M., (eds), Recent Results in Cancer Research

65:207-213, 1978.

17. Murphy, S.B., Aur, R.J.A., and Hustu, H.O.: Patterns of Presentation and Relapse in Childhood Non-Hodgkin's

Lymphoma. In, Crowther, D., (ed), Advances in Medical Oncology, Research and Education, Vol. 7, Leukemia and

Non-Hodgkin Lymphoma, pp. 99-103. Proceedings, XIIth International Cancer Congress, Pergamon Press, Ltd.,

Oxford, 1979.

18. Mauer, A.M. and Murphy, S.B.: Kinetic studies of cells in childhood leukemias. Am. J. Clin. Pathol., Vol. 72:753-755,

1979.

19. Murphy, S.B.: The lymphomas, lymphadenopathy, and histiocytoses. In, D. Nathan and F. Oski, (eds), Hematology of

Infancy and Childhood, Chap. 31, 2nd edition, pp. 1023-1065, W.B. Saunders, Co., Philadelphia, 1980.

20. Murphy, S.B.: Classification, staging and end results of treatment of childhood non-Hodgkin's lymphomas:

dissimilarities from lymphomas in adults. Semin. Oncol. 7:332-339, 1980.

21. Mauer, A.M., Murphy, S.B., and Hayes, F.A.: Growth regulation of human malignant cells. In, McKinnell, R.G.,

Diberardino, M.A., and Bergad, R.D.,(eds), Differentiation and Neoplasia. Results and Problems in Cell Differentiation,

Vol. II, pp. 228-232, Springer- Verlag, New York, 1980.

22. Murphy, S.B.: Ontogeny of the immune response, an immunologic basis for childhood neoplasms. (Letter to the Editor)

J. Pediatr. 98:503, 1981.

23. Murphy, S.B. and Donaldson, S.S.: Pediatric lymphoma. In, Carter, S.K., Glatstein, E., and Livingston, R.B. (eds),

Principles of Cancer Treatment, Chap. 103, McGraw-Hill, pp. 882-890, 1981.

24. Rivera, G., Dahl, G.V., Murphy, S.B., Bowman, W.P., Aur, R.J., Avery, T.L., and Simone, J.V.: VM26 therapy in

children with drug- refractory lymphocytic leukemia. Cancer Chemother. Pharmacol. 7:169-172, 1982.

25. Rivera, G., Dahl, G., Murphy, S.B., Bowman, W.P., Aur, R.J., Avery, T.L., and Simone, J.V.: VM26 therapy in children

with drug- refractory lymphocytic leukemia. In, Cortes Funes, H. and Rozencweig, M., (eds), New Approaches in

Cancer Therapy, Vol. 11, p. 59. Raven Press, New York, 1982.

26. Rivera, G., Dahl, G.V., Murphy, S.B., Bowman, W.P., Aur, R.J., Avery, T.L., and Simone, J.V.: Teniposide [VM-26]

therapy in children with drug-refractory lymphocytic leukemia. Chemioterapia 1:186-190, 1982.

27. Murphy, S.B.: Histiocytosis X. In Vincent C. Kelley (ed), Practice of Pediatrics, Vol. 5, Chapter 76, pp. 1-15, Harper &

Row, Philadelphia, 1982.

of 32

28. Murphy, S.B.: Difficulties in sickle cell states. In, Cooperman, L.H. and Orkin, F.K., (eds), Complications in

Anesthesiology, Chap. 44, J.B. Lippincott pp. 476-485, 1983.

29. Rivera, G., Dahl, G.V., Murphy, S.B., Bowman, W.P., Abromowitch, M., Ochs, J., Pui, C-H., Kalwinsky, D.K., Avery,

T.L., George, S.L., and Simone, J.V.: The epipodophyllotoxin VM-26 in treatment of high risk acute lymphoblastic

leukemia: Rationale and early results. In, Murphy, S.B. and Gilbert, J.R., (eds), Leukemia Research: Advances in Cell

Biology and Treatment. pp. 213-220, Elsevier Science Publishing Co., Inc., New York, 1983.

30. Murphy, S.B. and Gilbert, J. (eds): Leukemia Research: Advances in Cell Biology and Treatment. Elsevier Science

Publishing Co., Inc., New York, 1983.

31. Mirro, J., Melvin, S., Metzger, D., Look, A.T., and Murphy, S.B.: Changes in cell surface antigen expression during

myelocytic and monocytic cell differentiation. In, Bernard, A., Boumsell, L., Dausset, J., Milstein, C., and Schlossmann,

S.F. (eds), Leucocyte Typing. Springer-Verlag, pp. 442-446, 1984.

32. Murphy, S. and Jaffe, E.: Editorial. Retrospective: Terminal transferase and lymphoblastic neoplasms. New Engl. J.

Med. 311:1373-1375, 1984.

33. Murphy, S.B.: Afterword: Acute lymphoblastic leukemia: Research imperatives and practical realities. Sem. Onc.

XII(2):192-194, 1985.

34. Murphy, S.B., Bowman, W.P., Hustu, H.O., and Berard, C.W.: Advanced Stage (III-IV) Burkitt's lymphoma and B-cell

ALL in children: Kinetic and pharmacologic rationale for treatment and recent results (1979-1983). In, Lenoir, G.,

O'Conor, G.T., and Olweny, C.L.M. (eds): Burkitt's Lymphoma. IARC Scientific Publications No. 60, pp. 405-418,

Lyon, 1985.

35. Murphy, S.B.: Current status of the curability of children with Hodgkin's disease: An assessment of the risk:benefit ratio

of modern therapy. In, F. Cavalli, G. Bonadonna, M. Rozencweig (eds), Malignant Lymphoma and Hodgkin's Disease:

Experimental and Therapeutic Advances, Martinus Nijhoff, Publisher, pp. 603-609, 1985.

36. Murphy, S.B.: Strategies for management of childhood non-Hodgkin's lymphomas based upon stage and

immunopathologic subtype, rationale and current results. In, F. Cavalli, G. Bonadonna, M. Rozencweig (eds),

Malignant Lymphoma and Hodgkin's Disease: Experimental and Therapeutic Advances, Martinus Nijhoff, Publisher, pp.

627-632, 1985.

37. Murphy, S.B., Dahl, G.V., Look, A.T., Evans, W.E., Ochs, J., Abromowitch, M., Pui, C.-H., Bowman, W.P., Simone, J.V.,

Kalwinsky, D., George, S., Mirro, J., Williams, D., Dow, L.W. and Rivera, G.: Recent results from Total Therapy Study

X for standard and high risk acute lymphoblastic leukemia in children: Recognition of new clinical and biologic risk

features. In, R. Neth (ed), Modern Trends in Human Leukemia VI. Springer-Verlag, 29:78-81, 1985.

38. Murphy, S.B.: Guest editor, for issue on Acute Lymphoblastic Leukemia, Seminars in Oncology, XII(2), 1985.

39. Amylon, M.D., Link, M.P. and Murphy, S.B.: Malignant T-cell and other nonHodgkin's lymphomas. In, A. Barrett and

P.A. Voute (eds), Chapter 16, Cancer in Children, Second Edition, Springer-Verlag, pp. 152-163, 1986.

40. Murphy, S.B., and Bleyer, W.A.: Cranial irradiation is not necessary for central-nervous-system prophylaxis in

pediatric non- Hodgkin's lymphoma. Int. J. Radiation Oncol. Biol. Phys. (Editorial) 13:467-68, 1987.

41. Murphy, S.B.: Histiocytosis. In, A. Rudolph (ed), Chapter 22.3.8 Pediatrics, 18th edition, Appleton & Long, pp. 1129-

1132, 1987.

42. Murphy, S.B.: Non-Hodgkin's lymphoma. In A. Rudolph (ed), Chapter 22.2.1 Pediatrics, 18th edition, Appleton &

Long, pp. 1104-1107, 1987.

43. Murphy, S.B.: The Lymphomas and Lymphadenopathy. In, D. Nathan and F. Oski (eds), Hematology of Infancy and

Childhood, Chapter 35, 3rd Edition, W.B. Saunders Co., Philadelphia, pp. 1086-1117, 1987.

of 32

44. Murphy, S.B.: Childhood lymphomas in current perspective. In R.P. Gale and D.W. Golde (eds) Recent Advances in

Leukemia and Lymphoma, UCLA Symposia on Molecular and Cellular Biology, New Series, Vol. 61, Alan R. Liss, Inc.,

New York, NY, pp. 513-520, 1987.

45. Rivera, G.K., Kovnar, E., Pui, C-H., Dahl, G.V., Abromowitch, M., Ochs, J.J., Look, A.T., Kalwinsky, D.K., Mirro, J.,

Dow, L.W., and Murphy, S.B.: Limiting toxicities during intensified remission induction chemotherapy for childhood

acute lymphocytic leukemia. In, Buchner, Schellong, Hiddemann, Urbanitz, Ritter (eds), Hematology and Blood

Transfusion, Springer-Verlag, Berlin Heidelberg, 30:156-160, 1987.

46. Mirro, J., Zipf, T.F., Pui, C-H., Kitchingman, G., Williams, D., Melvin, S., Murphy, S.B., and Stass, S.: Acute mixed

lineage leukemias: clinicopathologic correlations and prognostic significance. In: 1987 Yearbook of Cancer, Yearbook

Medical Publishers, Inc., Chicago, pp. 219-222, 1987.

47. Rivera, G.K., Kalwinsky, D.K., Mirro, J., Pui, C-H., Abromowitch, M., Ochs, J., Furman, W., Santana, V., Look, A.T.,

Dow, L., Crist, W., and Murphy, S.B.: Intensified chemotherapy for childhood lymphoblastic leukemia: modifications

and results of induction treatment in St. Jude Study XI. II World Basque Congress. Proceedings of Conference on

Pediatric Oncology, 1987.

48. Murphy, S.B.: Open Forum: Reply to M.F. Greaves. Origins of childhood acute lymphoblastic leukemia. Leukemia

2:480-483, 1988.

49. Murphy, S.B. Book Review, Principles and Practice of Pediatric Oncology, J. Natl. Cancer Inst., 81:876, 1989.

50. Murphy, S.B.: Management of pediatric lymphomas. Current Opinion in Oncology 1:42-46, 1989.

51. Murphy, S.B.: Staging laparotomy for Hodgkin's Disease in Children. Commentary, p. 377, Yearbook of Pediatrics,

J.A. Stockman, III and F.A. Oski (eds.), Yearbook Publishers, 1990.

52. Murphy, S.B.: Childhood lymphomas. Chapter 75, in Hematology, Basic Principles and Practice, (E.J. Benz, H.J.

Cohen, B. Furie, R. Hoffman, and S.J. Shattil, eds.), pp 983-990, Churchill Livingstone, New York, 1990.

53. Murphy, S.B. and Magrath, I.: Pediatric lymphomas: current results and prospects. Annals of Oncology, Vol. 2,

Supplement 2, (J. Ultmann, ed.), 219-223, 1991.

54. Murphy, S.B., Cohn, S.L., Craft, A.W., Woods, W.G., Sawada, T., Castleberry, R.P., Levy, H.L., Prorok, P.C., Hammond,

G.D.: Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer

Society Workshop on Neuroblastoma Screening, Lancet 337:344-346, 1991. Reprinted in Ca, A Journal for Clinicians,

41: 227-230, 1991.

55. Murphy, S.B.: Acute Megarkaryoblastic Leukemia. Commentary, p 368-369, Yearbook of Pediatrics, F.A. Oski and J.A.

Stockman III, (eds). Yearbook Publishers, 1991.

56. Murphy, S.B.: Secondary Acute Myeloid Leukemia Following Treatment with Epipodophyllotoxins (Editorial) J. Clin

Oncol, 11: 199-201, 1993.

57. Murphy, S.B., and Chadwick, E.C.: HIV and Smooth Muscle Tumors, (Letter to the Editor) Pediatrics, 91:1020, 1993.

58. Murphy, S.B., Ades, T., Eaton, A. et al Resources for Care. Findings and Recommendations of Working Group.

American Cancer Society Workshop on Children and Cancer. Cancer 71 (Suppl.) 3216-17, 1993.

59. Katz, J., Hvizdala, E., Shuster, J., Falletta, J.M, Schwenn, M., and Murphy, S.B. Ten Year's Experience with LSA2-L2.

Therapy for Childhood Advanced Lymphoblastic Lymphoma. (Letter to the Editor). J. Clin. Oncol., 11: 2054-55, 1993.

60. Murphy, S.B. Hodgkin’s Disease. Commentary, Yearbook of Pediatrics, J.A. Stockman, III, (Editor), Yearbook

Publisher, 1994.

61. Murphy, S.B. Pediatric Lymphomas: Recent Advances and Commentary on Ki-1-positive anaplastic large cell

of 32

Lymphomas of Childhood. Annals of Oncology, 5 (Suppl 1):S31-S33, 1994.

62. Murphy, S.B. Pediatric Cancer in the United States. Commentary, Yearbook of Pediatrics. J.A. Stockman, III (Editor),

Yearbook Publishers, pp. 412-413, 1995

63. Murphy, S.B. The National Impact of Clinical Cooperative Group Trials for Pediatric Cancer. Med and Ped Onc, 24:

279-280, 1995.

64. McClain, K.L., Joshi, V.V., Murphy, S.B.. Cancers in Children with HIV Infection. Hematology/Oncology Clinics of

North America, 10 (No.5), pp1189-1201, 1996.

65. Murphy, S.B.. Managed Care and Cooperative Groups, (Editorial), Oncology Times, May, 1996.

66. Camitta, B.M., Pullen, J., Murphy, S.B.. Biology and Treatment of Acute Lymphocytic Leukemia in Children. Seminars

in Oncology, 24, (No.1), pp 83-91, 1997.

67. Murphy, S.B., The Pediatric Predicament. (...on Preserving the Environment for Medical Students and Resident

Education). Harvard Medical Alumni Bulletin 72, 42-43, 1998.

68. Murphy, S.B., Commentary Non-Hodgkin’s Lymphoma. Cancer Case Presentations: The Tumor Board. Commission on

Cancer of the American College of Surgeons. 3. No. 2. Lippincott, Williams & Wilkins, 1999.

69. Morgan, E.R., and Murphy, S., B. Care of Children Who are Dying of Cancer. (Editorial), New Engl. J. Med. 342:347-

8, 2000.

70. Murphy, S.B. Book Review, Childhood Leukemias, Oncology, 14:366, 2000.

71. Murphy, S.B., Biology and Therapy of B-cell Lymphomas in Children: Are There Lessons Applicable to Adult B-cell

Lymphomas? American Society of Clinical Oncology. 2001 Educational Book, pp 247-251. M. Perry, Editor, ASCO,

2001.

72. Murphy, S.B. Clinical Trials: Risks and Benefits, J. Peds Hem/Onc., 23, 564-567, 2001.

73. Murphy, S.B. Clinical Trials: Risk and Benefits. Seminars in Pediatric Surgery, 11:156-161, 2002.

74. Murphy, S.B. Research Involving Long Term Survivors of Childhood and Adolescent Cancer: Issues Impacting Design

and Conduct of Clinical Trials, in Management of Pediatric and Adolescent Survivors of Childhood Cancer, Current

Problems in Cancer, volume 27, Issue 4, pp 225-235, Mosby, July/August 2003.

75. Murphy, S.B. and Shuster, JJ., Childhood Cancer, Chapter 7, pp 101-116, in Textbook of Clinical Trials, S. Green and

D. Machin, eds. John Wiley & Sons, 2004.

76. Caldwell, P., Murphy, S.B., Butow, P, and Craig, J. Clinical Trials Involving Children, Lancet, 364:803-811, 2004.

77. Murphy, S.B. Conquering Childhood Cancer: Challenges and Opportunities. San Antonio Medicine, 57:26-27, 2004.

78. Murphy, S.B. Introduction/Historical Background, Chapter 5, pp 85-89, in Pediatric Lymphomas, H. Weinstein, M. Link,

and M. Hudson, eds., Springer Verlag, 2007

79. Murphy, S.B. and Shuster, J.J. Childhood Cancer, Chapter 5, pp 63-80, in Textbook of Cllinical Trials, Second Edition,

D. Machin, S. Day and S. Green, eds. John Wiley & Sons, 2006.

80. Murphy, S.B. Tailoring Treatment to Prognosis for Childhood Localized non-Hodgkin’s Lymphoma. J Clin Oncol,

26:1020-1021, 2008.

81. King, J., Lawrence, T.S., Murphy, S.B., Davidson,N.E., and Mayer, R.J. The ASCO Cancer Foundation Grants Program:

A 25 Year Report and a Look Toward the Future. J. Clin. Oncol. 28:1616-1621, 2010.

of 32

82. Murphy S. and Patlak M., Rapporteurs. A Foundation for Evidence-Driven Practice: A Rapid Learning System for Cancer

Care: Workshop Ssummary. IOM (Institute of Medicine) 2010. Washington, DC: The National Academies Press, 2010.

83. Murphy SB and Land, VJ. Obituary. Teresa J. Vietti M.D. 1927-2010 .Pediatric Blood and Cancer 55:1-2, 2010.

84. Simpson L., Peterson L., C. Lannon, C., Murphy S.B., Goodman C., Ren X.,and Zaijcek, A...Special Challenges

in Comparative Effectiveness Research on Children’s and Adolescents’Health.. Health Affairs,29: 1849-1856, 2010.

85. Murphy S.B. Positive Benefits of Cooperative Group Membership: Being Part of a Networked Rapid Learning System.

Pediatric Blood and Cancer, 55:601-602, 2010.

86. Kean M.A., Abernethy A., Clark A., Dalton W.S., Pollock B.H., Shulman L.N., and Murphy S. B. Achieving Data Liquidity in

the Cancer Community: Proposal for a Coalition of All Stakeholders. Discussion Paper.

http://www.iom.edu/perspectives/2012

Abstracts

1. Murphy, S. and Oski, F.A.: Congenital dyserythropoietic anemia: Report of two cases. Pediatr. Res. 6:371, 1972.

2. Bradley, T.B., Wohl, R.C., Murphy, S.B., Oski, F.A., and Bunn, H.F.: Properties of hemoglobin Bryn Mawr 85 Phe_Ser.

A new spontaneous mutation producing an unstable hemoglobin with high oxygen affinity. Blood 408:947, 1972.

3. Stuart, M., Kinney, T., Murphy, S., and Oski, F.: Idiopathic autoimmune hemolytic anemia (AIHA) in childhood:

Diagnosis, treatment and outcome in 13 patients. Pediatr. Res. 7:361, 1973.

4. Walker, R.D., Murphy, S., and Turner, J.E.: Histiocytosis X. Proc. Am. Acad. Oral Pathol., 1975.

5. Murphy, S., Dahl, G., Rivera, G., Mauer, A., and Simone, J.: Cytokinetic observations on the effects of either

simultaneous or sequential administration of cytosine arabinoside (Ara-C) and methotrexate (MTX) in childhood

lymphocytic leukemia (ALL) in relapse. Proc. AACR 17:121, 1976.

6. Murphy, S.B. and Mauer, A.: Cell kinetic observations in childhood nonHodgkin's lymphoma. (Abstract #728) Proc.

AACR 18:182, 1977.

7. Murphy, S.B. and Hustu, H.O.: A randomized trial of combined modality therapy in childhood non-Hodgkin's

lymphoma. (Abstract #C-231) Proc. ASCO-AACR 19:364, 1978.

8. Ransom, J.L., Powazek, M., Goff, J.R., Anderson H.R., and Murphy, S.B.: Neuropsychological late sequelae of

Histiocytosis X. Pediatr. Res. 12 (4, part 2):472, 1978.

9. Murphy, S.B. and Caces, J.: Limited utility of bone marrow biopsy in staging children with non-Hodgkin's lymphoma.

Blood 52(5), (Suppl.1):573, 1978.

10. Frizzera, G. and Murphy, S.B.: Follicular (nodular) lymphomas in childhood. A clinicopathologic study of eight cases.

Proc. Int. Acad. Pathol., 68th Annual Meeting, 1979.

11. Pratt, C.B., Murphy, S.B., Green, A.A., Aur, R.J.A., et al.: Carcinomas in children. (Abstract #626) Proc. AACR 20:155,

1979.

12. Rivera, G., Murphy, S.B., Wood, A., Dahl, G.V., Bowman, W.P., and Aur, R.J.A.: Combination chemotherapy with

prednisone, vincristine, and the epipodophyllotoxin VM-26 for refractory childhood lymphocytic leukemia (ALL). Blood

54(5), (Suppl. 1):205a, 1979.

of 32

13. Look, A.T., Dahl, G.V., Rivera, G., Murphy, S.B., Mason, C., Senzer, N., and Mauer, A.M.: Clinical and cell kinetic

studies of combination chemotherapy with the epipodophyllotoxin VP-16 and 5- azacytidine for refractory acute

nonlymphocytic leukemia (ANLL). Blood 54(5), (Suppl. 1):195a, 1979.

14. Dahl, G.V., Murphy, S.B., Amadori, S., Simone, J.V., and Mauer, A.M.: Sequential studies of marrow blast

[3H]-thymidine labeling indices (L1) during remission induction of acute non-lymphocytic leukemia (ANLL): An

indicator for "high risk" ANLL. Blood 54(5), (Suppl. 1):185a, 1979.

15. Murphy, S.B., Dahl, G.V., and George, S.: Determination of the significance of initial and serial in vitro marrow blast

[3H]-TdR labeling indices (LI%) in human myeloid leukemia (AML). (Abstract #27) 4th Annual Cell Kinetics Society

Meeting, Cell Tissue Kinetics, 1980.

16. Chi'en, L.T., Kalwinsky, D.K., Peterson, G., Pratt, C.B., Murphy, S.B., Hayes, A., Green, A.A., Johnston, B., Chen, L-S.,

and George, S.: Epidural spinal compressions in childhood cancer patients. Neurology 30:378-379, 1980.

17. Murphy, S. and Hustu, O.H.: Strategies for therapy of non- Hodgkin's lymphoma based upon primary site, extent of

disease and immunopathologic subtype. 12th Annual Meeting, International Society of Pediatric Oncology, 1980.

18. Murphy, S.B.: The implications of adjuvant therapy for children. 3rd International Conference on the Adjuvant Therapy

of Cancer, 1981.

19. Champion, J.E., Naegele, R.F., Henle, W., Henle, G., and Murphy, S.: A clinical correlation between Epstein-Barr

virus-specific antibody titers and disease activity in American children with nasopharyngeal carcinoma (NPC). Proc.

AACR 22:168, 1981.

20. Rivera, G., Dahl, G.V., Bowman, W.P., Aur, R.J., Murphy, S.B., and Tsiatis, A.: Prolonged second marrow remission in

children with lymphocytic leukemia (ALL) treated with VM-26 and cytosine arabinoside (ARA-C). Proc. ASCO 22:481,

1981.

21. Murphy, S.B., Hustu, H.O., Rivera, G., Soper, R.G., and Berard, C.W.: A prospective trial evaluating a reduction in

intensity of therapy for children with non-Hodgkin's lymphoma (NHL) who have a good prognosis based upon initial

disease location and extent Stage I-II. Proc. ASCO 22:510, 1981.

22. Look, A.T., Melvin, S.L., Murphy, S.B., Bowman, W.P., and Mauer, A.M.: Heterogeneity of expression of the common

acute lymphocytic leukemia antigen (CALLA) in childhood acute lymphocytic leukemia (ALL) as measured by

quantitative immunofluorescence with flow cytometry (FCM). Proc. AACR 22:307, 1981.

23. Look, A., Melvin, S., Murphy, S.B., Williams, D., Brodeur, G.M., and Mauer, A.M.: Pretreatment flow cytometry (FCM)

of DNA content in childhood acute lymphocytic leukemia (ALL). Proc. Cell Kinetics Society, 1981.

24. Rivera, G., Dahl, G., Murphy, S., Bowman, P., Aur, R., and Simone, J.: Epipodophyllotoxin therapy in children with drug

refractory lymphocytic leukemias. International Cancer Society, 1981.

25. Murphy, S.B., Hustu, H.O., Rivera, G., Bowman, W.P., and Dahl, G.V.: Pre-treatment stratification of childhood

non-Hodgkin's lymphoma according to primary site, clinical stage and immunopathologic subtype. Current results of

combined modality therapy. International Conference on Malignant Lymphomas, Lugano, Switzerland, 1981.

26. Pui, C-H., Costlow, M.E., Chen, L., Murphy, S.B., and Dahl, G.V.: Glucocorticoid receptors (GR) in childhood acute

lymphocytic leukemia (ALL). Proc. ASCO, 1982.

27. Look, A.T., Williams, D.L., Brodeur, G.M., Murphy, S.B., Dahl, G.V., and Mauer, A.M.: Multiple stemlines in childhood

acute lymphoblastic leukemia (ALL) determined by flow cytometry (FCM). Proc. AACR, 1982.

28. Rivera, G., Bowman, P., Dahl, G., Avery, T., Murphy, S., and Simone, J.: Drug refractory acute lymphocytic leukemia

(ALL) - Therapy with the epipodophyllotoxin, VM-26. 13th International Cancer Congress, 1982.

29. Look, A.T., Melvin, S.L., Murphy, S.B., and Mauer, A.M.: A method for flow cytometric determination of cell cycle

dependent expression of surface antigens in childhood acute lymphoblastic leukemia (ALL). Cell Kinetics Society, 1982.

of 32

30. Dow, L., Dahl, G.V., Murphy, S.B., and Mauer, A.M.: Relationship of blast proliferative activity and prognosis in

childhood acute lymphoblastic and acute nonlymphocytic leukemia. International Society of Hematology, 1982.

31. Look, A.T., Melvin, S.L., Murphy, S.B., Ferrone, S., and Mauer, A.M.: Cell cycle dependent expression of Ia antigens in

childhood acute leukemia. Blood 60(5), (Suppl. 1):132a, 1982.

32. Murphy, S.B., Sinkule, J., and Rivera, G.: Clinical and biochemical pharmacologic observations of the effects of constant

intravenous infusions of 2'-deoxycoformycin (DCF) in children with refractory acute lymphoblastic leukemia (ALL).

Blood 60(5), (Suppl. 1):157a, 1982.

33. Stass, S., Peiper, S., Melvin, S., Folds, J., Williams, D., Mirro, J., Look, T., and Murphy, S.: Simultaneous expression of

common acute lymphoblastic leukemia antigen and myeloperoxidase - evidence for mixed phenotypic expression in acute

leukemia. Blood 60(5), (Suppl. 1):140a, 1982.

34. Murphy, S.B. and Bowman, W.P.: Combination intensive high-dose chemotherapy of short duration for advanced stage

(III-IV) Burkitt- type B-cell non-Hodgkin's lymphoma (B-NHL) and B-cell acute lymphoblastic leukemia (B-ALL) in

children. 3rd International Symposium on Therapy of Acute Leukemias, Rome, Italy, 1982.

35. Murphy, S.B., Look, A.T., Dow, L.W., and Melvin, S.: Proliferation patterns of childhood leukemias and lymphomas:

Biologic correlates with immune phenotype. 3rd International Symposium on Therapy of Acute Leukemias, Rome, Italy,

1982.

36. Rivera, G., Dahl, G.V., Evans, W.E., and Murphy, S.B.: New drugs for the treatment of childhood leukemia. 3rd

International Symposium on Therapy of Acute Leukemias, Rome, Italy, 1982.

37. Murphy, S.B., Dahl, G.V., and Rivera, G.: Management of Stage III-IV lymphoblastic lymphomas and high-risk acute

lymphoblastic leukemias with a mediastinal mass with an intensive, multiple-drug protocol incorporating VM-26 and

Ara-C. 3rd International Symposium on Therapy of Acute Leukemias, Rome, Italy, 1982.

38. Bowman, P., Rivera, G., Dahl, G., Kalwinsky, D., Ochs, J., Murphy, S., Abromowitch, M., Pui, C., Look, T., Mirro, J. and

Simone, J.: Treatment of acute lymphoblastic leukemia in children. 3rd International Symposium on Therapy of Acute

Leukemias, Rome, Italy, 1982.

39. Sinkule, J.A., Murphy, S.B., Evans, W.E., and Rivera, G.: Pharmacodynamics of continuous infusion 2'-deoxycoformycin

(dCF) in refractory acute lymphoblastic leukemia (ALL). Proc. AACR 24:135, 1983.

40. Dahl, G., Murphy, S., Abromowitch, M., Kalwinsky, D., Pui, C-H., Ochs, J., Mirro, J., Look, T., and Rivera, G.: VM26

plus ara-C as initial and intermittent treatment for Stage III-IV lymphoblastic lymphoma and acute lymphoblastic

leukemia with a mediastinal mass. Proc. ASCO 2:216, 1983.

41. Pui, C-H., Costlow, M.E., Murphy, S.B., Rivera, G., Givens, D.R., and Dahl, G.V.: Glucocorticoid receptors (GR) in

relapsed acute lymphocytic leukemia (ALL). Proc. AACR 24:126, 1983.

42. Mirro, J., Melvin, S.L., Metzger, D.W., Look, A.T., and Murphy, S.B.: Changes in surface antigen expression during

monocytic differentiation. Proc. Am. Pediatr. Soc., 1983.

43. Bowman, W.P., Buchanan, G.H., and Murphy, S.B.: Total therapy-B for B-cell acute lymphocytic leukemia (B-ALL) and

stage III-IV B-cell non-Hodgkin lymphoma (B-NHL). Proc. ASCO 2:210, 1983.

44. Look, A.T., Melvin, S.L., Brown, L.K., and Dockter, M.E.: Quantitative variation of the common acute lymphoblastic

leukemia antigen (gp100) on leukemic marrow blasts. Blood 62, Suppl. 1, 177a, 1983.

45. Look, A.T., Roberson, P.K., Williams, D.L., Bowman, W.P., Pui, C.-H., Abromowitch, M., and Murphy, S.B.: Prognostic

importance of blast cell hyperploidy determined by flow cytometry in childhood acute lymphoblastic leukemia. Blood 62,

Suppl. 1, 177a, 1983.

46. Melvin, S., Dahl, G., Abromowitch, M., Murphy, S., and Stass, S.: Comparison of T-cell differentiation schemes in T-cell

acute lymphocytic leukemias (T-ALL) and T-cell lymphoblastic lymphomas (T- LL). Blood 62, Suppl. 1, 178a, 1983.

of 32

47. Bunin, N., Hvizdala, E., Link, M., Callihan, T., Hustu, H.O., Warm, M., Berard, C., and Murphy, S.: Mediastinal

non-lymphoblastic lymphomas (NLBL) in children: Clinical pathological features. Proc. ASCO 3:240, 1984.

48. Link, M., Donaldson, S., Berard, C., and Murphy, S.: Effective therapy with reduced toxicity for children with localized

non- Hodgkin's lymphoma (NHL). Proc. ASCO 3:251, 1984.

49. Kitchingman, G.R., Stass, S., Williams, D., Mirro, J. and Murphy, S.B.: Immunoglobulin heavy-chain gene

rearrangements in childhood acute lymphoblastic leukemia (ALL): Implications for lineage fidelity and clonality. Blood

64, (5)Suppl. 1:193A, 1984.

50. Weiss, K., Dow, L., Williams, D., Dahl, G., Kalwinsky, D., Johnson, F.L., Murphy, S., and Stass, S.: Monosomy-7

syndrome in childhood. Blood 64, Suppl. 1, 151a:1984.

51. Ochs, J., Abromowitch, M., Murphy, S., Rudnick, S., and Sorrell, M.: Recombinant a-2 Interferon (aIFN) in refractory

childhood acute lymphoblastic leukemia (ALL) and chronic myelogenous leukemia. Proc. ASCO 4:168, 1985.

52. Kitchingman, G.R., Mirro, J., and Murphy, S.B.: Immunoglobulin and T-cell receptor gene rearrangements in childhood

acute leukemias: Implications for lineage fidelity and clonality. Proc. Miami Winter Symposium: Molecular Biology of

the Immune System, 1985.

53. Winick, N., Buchanan, G., Murphy, S.B., Yu, A.: Deoxycoformycin in the treatment of T-cell acute lymphoblastic

leukemia (T-ALL) early in second remission. Blood 66(5)(Suppl. 1):211a, 1985.

54. Raimondi, S., Williams, D., Kalwinsky, D., Pui, C-H., and Murphy, S.B.: Abnormalities of the short arm of chromosome 9

in childhood acute lymphoblastic leukemia (ALL). Blood 66(5) (Suppl. 1):244a, 1985.

55. Williams, D.L., Raimondi, S.C., Murphy, S.B., Ochs, J.S., Abromowitch, M., Mirro, J., and Rivera, G.: Improved

cytogenetic identification of abnormal clones in childhood acute lymphoblastic leukemia (ALL) reveals significant new

information. Blood 66(5)(Suppl. 1):247a, 1985.

56. Pui, C-H., Williams, D.L., Kalwinsky, D.K., Look, A.T., Melvin, S.L., Dodge, R.K., Rivera, G.K., Murphy, S.B., and Dahl,

G.V.: Biologic features predict a poor treatment outcome for children with pre-B acute lymphoblastic leukemia (ALL).

Proc. ASCO 5:153, 1986.

57. Mirro, J., Jr., Dahl, G.V., Kalwinsky, D., and Murphy, S.B.: A phase II study of simultaneous continuous infusions of

teniposide (VM-26) and m-AMSA in relapsed acute leukemia. Proc. ASCO 5:154, 1986.

58. Abromowitch, M., Pui, C-H., Dahl, G., Bowman, W., Rivera, G., Kalwinsky, D., Mirro, J., Evans, W., Murphy, S., Ochs,

J.: St. Jude total therapy study X for standard-risk acute lymphocytic leukemia (ALL): 4-year follow-up. Proc. ASCO

5:162, 1986

59. Dahl, G., Pui, C-H., Kalwinsky, D., Ochs, J., Abromowitch, M., Mirro, J., Murphy, S., Rivera, G.K.: Teniposide (VM-26)

plus cytarabine (ara-C) improved outcome in extremely high-risk acute lymphocytic leukemia (ALL). Proc. ASCO 5:162,

1986.

60. Donaldson, S.S., Link, M.P., Shuster, J.J., Berard, C., and Murphy, S.B.: What is the role of involved field radiation

among children with localized non-Hodgkin's lymphoma? Amer. Soc. Therapeutic Radiation Oncology, 1986.

61. Pui, C-H., Raimondi, S.C., Murphy, S.B., Ribeiro, R.C., Dahl, G.V., Kalwinsky, D.K., Crist, W.M., and Williams, D.L.:

Blast cell cytogenetic features in infants with acute leukemia. Blood (Suppl 1) 68(5):262, 1986.

62. Bunin, N., Mirro, J., Raimondi, S., Behm, F., Murphy, S.B., Kitchingman, G.: Gene rearrangements as clonal markers at

diagnosis and relapse in childhood acute leukemia. Blood 68(5):661, 1986.

63. Goohra, R., Bunin, N., Mirro, J., Murphy, S.B., Cross, A.H., Behm, F.G., Quertermous, T., Seidman, J., and Kitchingman,

G.R.: Provocative pattern of rearrangements of the genes for the gamma- and beta-chains of the T-cell receptor (TCR) in

childhood acute lymphoblastic leukemias (ALL). Blood 68(5):904, 1986.

of 32

64. Rivera, G.K., Ochs, J., Roberson, P.K., Murphy, S.B., Mirro, J., Hustu, H.O., Kun, L.: Intensive salvage therapy for

isolated initial CNS relapses in childhood ALL. Blood 68(5):802, 1986.

65. Pui, C-H., Williams, D.L., Raimondi, S.C., Rivera, G.K., Look, A.T., Dodge, R.K., Behm, F.G., Crist, W.M., and Murphy,

S.B.: Blast cell hypodiploidy confers a poor prognosis in childhood acute lymphoblastic leukemia (ALL). Proc. ASCO

6:570, 1987.

66. Murphy, S.B., Mirro, J., Williams, D., Raimondi, S., Look, A.T., Kitchingman, G., Kalwinsky, D., Behm, F., Pui, C-H.,

Roberson, P., George, S., and Rivera, G.K.: Therapeutic dissection of the biologic heterogeneity of childhood leukemias

and lymphomas. J. Cell Biochem. Suppl. 11a:189, 1987.

67. Sullivan, M.P., Crist, W., Pullen, J., Jackson, J., Head, D., Borowitz, M., Murphy, S., and Shuster, J.: Childhood B-cell

acute lymphocytic leukemia (ALL) is unexpectedly clinically heterogenous: A Pediatric Oncology Group (POG) Study.

Proc. ASCO 6:148, 1987.

68. Link, M.P., Donaldson, S.S., Berard, C.W., Shuster, J.J., and Murphy, S.B.: High cure rate with reduced therapy in

localized non-Hodgkin's lymphoma (NHL) of childhood. Proc. ASCO 6:190, 1987.

69. Raimondi, S.C, Murphy, S.B., and Williams, D.L.: Newly defined clusters of translocations in childhood acute

lymphoblastic leukemia. 9th International Conference on Gene Mapping, Paris, France, September, 1987.

70. Stapleton, F.B., Strother, D.R., Roy, S. III, Wyatt, R.J., McKay, C.P., and Murphy, S.B.: Acute renal failure (ARF) in

children at onset of therapy for advanced stage Burkitt's lymphoma. National Kidney Foundation, Inc., 17th Annual

Scientific Meeting 1987.

71. Murphy, S.B., Hutchison, R., Fairclough, D., and Berard, C.W.: Non-Hodgkin's lymphoma (NHL) of childhood: an

analysis of a large single institution experience with the staging, histology, and response to treatment of 328 cases. Proc.

ASCO 7:226, 1988.

72. Amylon, M., Murphy, S., and Pullen, J., for the Pediatric Oncology Groups: Treatment of lymphoid malignancies

according to immune phenotype: Preliminary results in T-cell disease. Proc. ASCO 7:225, 1988.

73. Strother, D., Glynn-Barnhart, A., Kovnar, E., and Murphy, S.B.: Variability in cerebrospinal fluid methotrexate

disposition following intra-Ommaya therapy. A Proposal for Rational Dosing. Proc. AACR 29:188, 1988.

74. Pui, C-H., Behm, F.G., Raimondi, S.C., Dodge, R.K., George, S.L., Rivera, G.K., Mirro, Jr., J., Kalwinsky, D.K., Dahl,

G.V., Murphy, S.B., Crist, W.M., and Williams, D.L.: Secondary acute myeloid leukemia (AML) in childhood acute

lymphoblastic leukemia (ALL). Ped. Research. 25(4) Part 2, 155a, 1989.

75. Santana, V.M., Bunin, N., Strother, F., Behm, C.H., and Murphy, S.B.: MACOP-B: An effective therapy for children with

advanced stage large-cell non-Hodgkin's lymphoma (NHL). Proc. ASCO 8:278, 1989.

76. Mahmoud, H., Wang, W., Murphy, S.B., Gaber, O., and Vera, S.: Successful liver transplantation in a child with

Langerhans' Cell Histiocytosis (LCH). Am. Soc. Ped. Hem. Oncol., 1989.

77. Mahmoud, H., Wang, W., and Murphy, S.B.: Cyclosporin A (CSA) treatment of patients with advanced-stage

Langerhans' Cell Histiocytosis (LCH). Am. Soc. Ped. Hem. Oncol., 1989.

78. Mahmoud, H., Pui, C-H, Kennedy, W., Jaffe, H.S., and Murphy, S.B.: Phase I study of human recombinant interferon

gamma in children with refractory leukemia. Proc AACR, 1990.

79. Bowman, W.P., Shuster, J., Cook, B., Behm, F., Berard, C., and Murphy, S.B.: Results of treatment for advanced stage

(IV) diffuse small non-cleaved cell non-Hodgkin's (NHL) lymphomas and B(SIg+) Acute Lymphoblastic Leukemia (All):

The Pediatric Oncology Group (POG) Experience, 1986-89. Fourth International Conference on Malignant Lymphoma,

Lugano, 1990.

80. Dowd, M.D., Morgan, E., Murphy, S.B. and Langman, C.B., Serum erythropoietin levels in children with leukemia. Clin.

of 32

Res. 39:690A, 1991.

81. Ribeiro, R., Pui, C.-H., Hvizdala, E., Murphy, S.B., Falletta, J., Link, M., Sullivan, M., Pick, T., Fairclough, D., Sandlund,

J., Crist, W. and Berard, C. Childhood non-Hodgkin lymphoma (NHL) of rare histology. Proc. ASCO 10:284, 1991.

82. Katz, J.A., Amylon, M.D., Ravidrananath, Y., Stout, M., Shuster, J.J., Jacaruso, D., Murphy, S.B. Unexpected life-

threatening toxicity from high dose cytosine arabinoside (HDA) in childhood T-cell acute lymphoblastic leukemia (T-all)

and advanced stage lymphoblastic lymphoma (NHL): A Pediatric Oncology Group (POG) study. Blood 78 Suppl. 1, 38a

1991.

83. Bowman, W.P., Shuster, J., Cook, B., Behm, F., Pullen, J., Berard, C.W., Murphy, S.B. Improved survival for children

with B cell (SIg+) acute lymphoblastic leukemia (B-ALL) and stage IV small non-cleaved cell lymphoma (SNCCL). Proc.

ASCO 11:277, 1992.

84. Brecher, M., Murphy, S.B., Bowman, P., Sullivan, M.P., Shuster, J., and Berard, C.W. Results of Pediatric Oncology

Group (POG) 8616: A randomized trial of two forms of therapy for stage III diffuse, small non-cleaved cell lymphoma in

children. Proc. ASCO 11:340,1992.

85. Link, M.P., Shuster, J.J., Berard, C.W., Murphy, S.B., Nine Weeks of Chemotherapy Without Radiotherapy is Sufficient

Treatment for Most Children with Localized Non-Hodgkin's Lymphomas (NHL). Proc. ASCO 12:384, 1993.

86. Link, M.P., Shuster, J.J., Berard, C.W., and Murphy, S.B., Treatment of Children with Localized Non-Hodgkin's

Lymphomas (NHL) With Nine Weeks of Chemotherapy Without Radiotherapy, International Society of Pediatric

Oncology, (SIOP), 1993.

87. Hutchison, R.E., Berard, C.W., Shuster, J.J., Link, MP., Pick, T.E., and Murphy, S.B., Immunophenotype Influences

Survival In Pediatric Large Cell Lymphoma. Fifth International Conference On Malignant Lymphoma, Lugano, 1993.

88. Murphy, S.B., Amylon, M., Link, M.P., Bowman, W.P., Brecher, M., Pick, T., Berard, C.W., Hutchinson, R., and Shuster,

J.J., Recent Advances in Therapy of High-Grade T- and B-Cell Non-Hodgkin's Lymphomas (NHL) of Childhood. J. Cell.

Biochem. (Suppl.)17E, 257, 1993.

89. Kantarjian, H., O'Brien, S., Beran, M., Escudier, S., Pierce, S., Estev, E., Koller, C., Robertson, B., Andreeff, M.,

Keating, M., Bowman, P., Murphy, S., and Freireich, E., Modified Burkitt Regimen for Adult Acute Lymphocytic

Leukemia (ALL) - The Hyper-CVAD Program. Blood 82 (10) (Suppl. 1):329a, Med. Ped. Oncol. 21(8):550, 1993.

90. Katz, J.A., Schwenn, M., Amylon, M., Shuster, J.J., and Murphy, S.B., Evaluation of High Dose L-Asparaginase (ASP) in

Treatment of Childhood Advanced Stage Lymphoblastic Non-Hodgkin's Lymphoma (NHL): A Pediatric Oncology Group

(POG) Study. International Society of Pediatric Oncology (SIOP), 1993.

91. Pick, T., Weinstein, H., Schwenn, M., Hvizdalda, E., Tarbell, N., Shuster, J., Hutchinson, R., Berard, C., Murphy, S.B.

Treatment of the Advanced Large Cell Non-Hodgkin's Lymphoma in Childhood a Pediatric Oncology Group (POG)

Study. Blood 82(10) (Suppl. 1):333a, 1993.

92. McClain, K.L., Leach, C.T., Jenson, H.B., Joshi, V.V., Pollock, B.H., Parmley, R.T., DiCarlo, F.J., Chadwick, E.G.,

Murphy, S.B. Epstein-Barr Virus is Associated with Leiomyomas and Leiomyosarcomas of Children with AIDS. ICAAC,

Oct. 1994.

93. Kung, F.H., Desai, S., Goorin, A.M., Harris M.B., Krischer, J.P., Murphy, S.B., Pratt, C.B., Wiley, J.M., and Yu A.L.

Ifosfamide/Carboplatin/Etoposide (Ice) in Recurrent Malignant Non-Hodgkin's Lymphoma of Childhood. ASCO 13:393,

1994.

94. Joshi, V., Gagnon, G., Chadwick, E., Berard, C., McClain, K., Leach, C., Jenson, H., Murphy, S.B.. Mucosal Associated

Lymphoid Tissue (MALT) Lesions In Pediatric Patients Infected With Human Immunodeficiency Virus (HIV). Blood 86

(Suppl 1), 380a, 1995

95 Kantarjian, H., O’Brien, S., Beran, M., Keating, M., Koller, C., Robertson, L., Andreeff, M., Murphy, S.B., Freireich, E..

Update Of The Hyper-CVAD Program In Newly Diagnosed Adult Acute Lymphocytic Leukemia (ALL): Blood 86 (Suppl

of 32

1), 173a, 1995.

96. McClain, K., Wu, W., Joshi, V., Leach, C., Jenson, H., Pollock, B., Berard, C., Murphy, S. Lymphomas and B-Cell

Leukemias of Children with AIDS are Infrequently Associated with Mutations or Translocations of C-myc or With Epstein

Barr Virus. Blood 88 (Suppl 1) 379a, 1996.

97. Conway, J., Harcke, H., Geissler, G., Murphy, S., Ruge, J. Intraoperative Probe Guidance for Surgical Removal of

Neuroendocrine Tumors Using a New Radiopharmaceutical. SPR., 40th Annual Meeting, 1997.

98. Kung, F., Barbosa, J., Harris, M., Krischer, J., Laver, J., Murphy, S., for Pediatric Oncology Group, ICE therapy for

Recurrent Non-Hodgkin’s Lymphoma of Childhood. Med Ped. Oncol., 29:360,1997.

99. Suryanarayan, K., Shuster, J., Donaldson, S., Berard, C., Murphy, S., Link, M. Successful Treatment of Localized

Primary Lymphoma of Bone in Children Without Radiotherapy. ASCO Proc. 16:516a,1997.

100. Desai, S., Amylon, M., Schwenn, M., Laver, J., Shuster, J., Murphy S. Outcome of Advanced Stage (III-IV) Lymphoblastic

Non Hodgkin’s Lymphoma - A Pediatric Oncology Group (POG) Study. Med. Ped. Oncol. 29:356, 1997.

101. Laver, J., Desai, S., Schwenn, M., Hutchison, R., Kepner, J., Murphy, S. A Pilot Study for Treatment of Advanced Stage

Large Cell Non-Hodgkin’s Lymphoma Using Intermediate Dose MTX (ID MTX) HDARA-C. A Pediatric Oncology Group

(POG) Study. Med. Ped. Oncol. 29:437, 1997.

102. Link, M., Suryanarayan, K., Shuster, J., Donaldson, S., Berard, C., Murphy, S. Pediatric Oncology Group (POG).

Successful Treatment of Localized Primary Lymphoma of Bone in Children Without Radiotherapy. Med. Ped. Oncol.

29:376,1997.

103. Murphy, S.B., Jenson, H.B., McClain, K.L., Leach, T.C., Joshi,V.V. and Pollock, B.H. AIDS Related Tumors. Med. Ped.

Oncol. 29:381, 1997.

104. Griffin, T.C., Shuster, J.D., Buchanan, G.R., Wharam, M., Murphy, S.B., Camitta, B., Amylon, M.. Slow Reduction of

Peripheral Blood Blast Count is an Adverse Prognostic Factor In Childhood T-Cell Acute Lymphoblastic Leukemia (T-

ALL): A Pediatric Oncology Group Study. Proc. ASCO,17: 527a, 1998

105. Link, M.P.,Shuster,J.J., Hutchison, R.E., Schwenn.M.R., Donaldson,S.S., Murphy, S.B., Minimizing Therapy for Children

with Localized Non-Hodgkin’s Lymphomas of the Gastrointestinal Tract. A Pediatric Oncology Group Study. Proc.

ASCO, 17: 528a, 1998.

106. Sandlund, J.T., Murphy, S.B., Santana, V.M., Behm, F.G., Jones, D., Berard, C.W., Furman, W.L., Ribeiro, R.C., Crist,

W.M., Greenwald, C., Chen, G., Walter, A.W., Pui, C-H. Central Nervous System Involvement in Children with Newly

Diagnosed Non-Hodgkin’s Lymphoma. Blood,92 (Suppl 1), 244a, 1998.

107. Thomas, D., Kantarjian, H., Cortes, J., O’Brien, S., Pierce, S., Faderl, S., Murphy, S.B., Albitar, M., Keating, M.J. The

Hyper-CVAD Program in Burkitts-Type Adult Acute Lymphoblastic Leukemia., Blood 92, (Suppl 1), 402a, 1998.

108. Kantarjian,H., O’Brien, Keating, M.J., Cortes, J., Giles, F.J., Beran, M., Koller, C., Andreff,S., Pierce, S. Murphy, S.B.,

Freireich, E.J., Update of the Hyper-CVAD Dose Intensive Regimen in Adult Acute Lymphocytic Leukemia (ALL), Blood,

92 (Suppl 1), 313a, 1998.

109. Hutchinson, R.E., Finch, C., Kepner, J., Fuller, C., Bowman, P., Link, M., Schwenn, M., Laver, J., Desai, S., Barrett, D.,

Murphy, S.B.,Burkitt-Like Lymphoma is Immunophenotypically Different from Burkitt Lymphoma in Young Persons.

Submitted VII International Conference on Malignant Lymphomas, Lugano 1999.

110 Schwenn, M.R., Mahmoud, H.H., Bowman, W.P., Hutchison, R.E., Kepner, J., Murphy, S.B. Successful Treatment of

Small NonCleaved Cell (SNCC) Lymphoma and B Cell Acute Lymphoblastic Leukemia (B-ALL) with Central Nervous

System (CNS) Involvement: A Pediatric Oncology Group (POG) Study.Proc. ASCO 19:580a, 2000

111. Griffin, T., Mahmoud, H., Weitzman, S., Schwenn, M., Hutchison, R., Ricketts, R., Kepner, J., Murphy, S.B. Results of a

Pilot Study of Dose Intensification of Methotrexate (MTX) and Cyclophosphamide (CP) in Patients with Advanced-Stage

(III/IV) Small Non-Cleaved Non-Hodgkin’s Lymphoma and B-Cell ALL (B-ALL): A Pediatric Oncology Group

of 32

Study,Blood, 96:580a, 2000.

112. Vajpayee, N., Kepner, J., Link, M.P., Murphy, S.B., Desai, S., Schwenn, M., Tarbell, N., Fitzgerald, T.J., Hutchison, R.E.

Alk-Negative Cutaneous Anaplastic Large Cell Lymphoma (ALCL) in Children Frequently Relapses. A Pediatric

Oncology Group Study, Blood, 96:232b, 2000.

113. Thomas, D.A., Cortes, J., O’Brien, S., Giles, F.J., Faderl, S., Cabanillas, F., Murphy, S.B., and Kantarjian, H. Improved

Outcome with the Hyper-CVAD Regimen in Lymphoblastic Lymphoma, Blood, 96:833a, 2000.

114. Schwenn, M.R., Mahmoud, H., Bowman, W., Hutchinson, R.E., Kepner, J., Murphy, S.B. The Addition of VP-Ifosfamide

Intensification Did Not Improve Event-Free Survival (EFS) for Central Nervous System (CNS) Negative Patients with

Advanced-Stage Small Noncleaved Cell (SNCC) Lymphoma or B-Cell Acute Lymphoblastic Leukemia (B-ALL): A

Pediatric Oncology Group (POG) Study. Proc. ASCO 20:367a, 2001

115. Laver, J.E., Weinstein, H.J., Hutchison, R.E., Kepner, J., Murphy, S.B. Lineage-Specific Differences in Outcome for

Advanced Stage Large Cell Lymphoma in Children and Adolescents: Results of a Randomized Phase III Pediatric

Oncology Group Trial, Blood 98:345a, 2001.

116. Link, M.P., Devidas, M., Murphy, S.B., Behm, F.G., Hutchison, R. Favorable Treatment Outcome of Children with Early

Stage Large B-cell and Anaplastic Large Cell Lymphomas, Proc. ASCO, 23:795, 2004

117. Willman, C.L., Huining, K., Potter, J.W., Harvey, R.C., Atlas, S.R., Bedrick, E., Helman, P., Veroff, R.L., Chen, I-M.,

Carroll, A.J., Kerem, A., Xu, Y., Murphy, S.B., Bhojwani, D., Moskowitz, N., Carroll, W.L.,and Camitta, B. A Gene

Expression Classifer for Improved Risk Classification and Outcome Prediction in Pediatric Acute Lymphoblastic

Leukemia (ALL), Blood, 106, 11:225a, 2005.

NCI NIH Site Visits:

May 27-28, 1982 - Memorial Sloan-Kettering Cancer Center

October 6-9, 1982 - Stanford University

November 7-9, 1984 - University of Chicago

May 29-31, 1985 - University of Arizona

October 30, 1985 - Memorial Sloan- Kettering Cancer Center

June 9-10, 1986 - University of Arizona, Chair

February 9-11, 1987 - University of Texas Health Sciences Center, San Antonio, Chair

October 18-20, 1987 - Fred Hutchison Cancer Center, Seattle, Chair

February 15-17, 1988 - Children's Hospital of Philadelphia, Chair

July 10-11, 1989 - University of Arizona, Chair

March 18-20, 1992, M.D. Anderson Cancer Center, University of Texas, Chair

June 15-17, 1992, Fred Hutchison Cancer Center, Seattle

February 28-March 2, 1994, Wistar Institute, Chair

Ad hoc Site Visits:

November 2001, Institute of Cancer Research, Sutton, and University of Manchester, UK, Cancer Research Campaign

November 2004, Dana Farber-Harvard Cancer Center, Cancer Center Support Grant, practice site visit review, Chair

January, 2005, Reviewer and Consensus Group Panel Participant for European Commission’s 6th

Framework

Programme Cancer Research Proposals in Brussels, Belgium.

Institutional Committees:

St. Jude Children's Research Hospital

1976-77 Education Committee, Chairperson

1977-78 Equipment Review Committee, Chairperson

1979-80 Medical Records Committee, Chairperson

1979-80 Medical/Scientific Equipment Review Committee

1980-82 Planning Committee, International Symposium, Memphis, Chairperson

1981-83 Executive/Scientific Review Committee

1986-88 Credentials and Tenure Committee

1986-88 Medical Records/Patient Record System Committee, Chairperson

of 32

Northwestern University Medical School NUMS/Children's Memorial Hospital, CMH

1988-present Member, Medical Board, Children's Memorial Hospital

1988-89 Medical School Research Planning Group, Northwestern University Medical School

1989-95 Faculty Affairs Committee, Department of Pediatrics

1989-02 Cancer Center Advisory Board, Northwestern University

1990-95 Appointments, Promotions and Tenure Committee, Northwestern University Medical School

1989-02 Chairperson, Cancer Committee, Children's Memorial Hospital

1992-94 Children's Memorial Institute for Education and Research Faculty Advisory Committee

1992 Member, Search Committee, for Chairman, Department of Pediatrics, NUMS

1992 Member, Search Committee, for Chairman, Department of Radiation Oncology, NUMS

1993-94 Member, Task Force on Faculty, Outlook 21, NUMS

1994 Member, Search Committee for Head, Division of Critical Care, CMH

1994 Chair, Search Committee for Head, Emergency Medicine, CMH

1994-99 Member, Board of Directors, Pediatric Faculty Foundation, Department Practice Plan

1995-99 Member, Executive Committee, Director-at-Large, Children’s Memorial Foundation

1997-00 Member, University Faculty Reappointment, Promotion, Tenure and Dismissal Appeal Panel, NUMS

1997-98 Member, Search Committee, Head, Pediatric Cardiology, CMH

1999-01 Member, Steering Committee, Northwestern Medical Women Faculty Organization

1999-00 Member, Search Committee, Head, Pediatric Pathology, CMH, NUMS

University of Texas Health Science Center at San Antonio

2002-05 Member, Executive Research Committee

2004-06 Member, Search Committee for Chair of the Department of Molecular Medicine and Director of the

Institute of Biotechnology

2004-06 Member, Advisory Committee, General Clinical Research Center (GCRC)

2004-08 Member, Executive Committee, San Antonio Cancer Institute

2004-05 Member, Search Committee for the Chairman, Department of Pediatrics and Physician-in-Chief of Christus

Santa Rosa Children’s Hospital

2005 Member, Search Committee for the Medical School Dean

2005-08 Member, University Research Council

2005-06 Chair, Search Committee for Division Head of Hematology/Oncology, Department of Pediatrics

2006 Member, Core Planning Committee for the Dell Pediatric Research Institute, UT System, Austin

2006-08 Member, Conflicts of Interest Committee

The National Academies

2010-2012 Member, Committee to Review Studies on Human Subjects

2010-2012 Member, Committee for the Assessment of Cancer Risks in Populations near Nuclear Facilities

Invited Lectures and Presentations:

Since 1978:

October, 1978, XIIth International Cancer Congress, Buenos Aires, Argentina

September, 1980, International Society of Pediatric Oncology, Budapest, Hungary

November, 1980, 3rd Bristol-Meyers Symposium, Malignant Lymphomas, Stanford University

May, 1981, Deutsche Arbeitsgemeinshaft for Leukamie-Forschung (DAL) - German Pediatric Cooperative Clinical Trials

Group meeting, Frankfurt, W. Germany

August, 1981, International Conference on Malignant Lymphomas, Lugano, Switzerland

June, 1982, Symposium on Cancer Pharmacotherapy, Paris, France

December, 1982, 3rd International Symposium on Acute Leukemias, Rome, Italy

of 32

March, 1983, Cell Kinetic Society Meeting, Baltimore, Maryland

April, 1983, NCI, CTEP, DCT Sponsored New Drug Workshop, Bethesda, Maryland

May, 1983, ASCO Education Program, Meet the Professor Session, San Diego, California

December, 1983, Symposium on Burkitt's Lymphoma, sponsored by the International Agency for Research on Cancer (WHO),

Lyon, France

April, 1984, Joint Grand Rounds of the Department of Pediatrics and Plenary Session of the Peidmont Oncology Association,

Wake Forest University and Bowman Gray School of Medicine, Winston-Salem, North Carolina.

April, 1984, Pediatric Grand Rounds, Memorial Hospital - Sloan- Kettering Cancer Center and Department of Pediatrics,

Cornell University Medical College, New York, New York.

May, 1984, Meet the Experts Educational Program, Oncology Nursing Society, Toronto, Canada

June, 1984, Second International Conference on Malignant Lymphoma, Lugano, Switzerland.

June, 1984, Modern Trends in Human Leukemia VI, Wilsede, Germany.

December, 1984, American Society of Hematology, Education Program, Miami, Florida.

April, 1985, 14th Annual Symposium of Leukemia and Allied Diseases, Leukemia Society of America, Wichita, Kansas.

October, 1985, XXVIIIth Annual Meeting of Oncology, Hospital A.C. Camargo, San Paulo, Brazil.

December, 1986, American Society of Hematology, Education Program, San Francisco, California.

January, 1987, UCLA Symposium, Recent Advances in Leukemia and Lymphoma, Keystone, Colorado.

February, 1987, Mayo Oncology Society, Rochester, Minnesota.

June, 1987, Third International Conference on Malignant Lymphoma, Lugano, Switzerland.

June, 1987, Tenth Annual Meeting of Pediatric Hematology, Spanish Society of Pediatrics, Santander, Spain.

October, 1987, Annual Meeting and Educational Seminar of the Tumor Registrars Association of Tennessee, Memphis.

September, 1988, Pediatric Grand Rounds, Children's Memorial Hospital, Chicago, Illinois.

October, 1988, Pediatric Grand Rounds, University of Chicago.

October, 1988, Pediatric Grand Rounds, University of Illinois.

October, 1988, Surgical Grand Rounds, Children's Memorial Hospital, Chicago, Illinois.

January, 1989, Pediatric Grand Rounds, Johns Hopkins Hospital Children's Center, Baltimore, Maryland.

January, 1989, Multidisciplinary Clinical Conference Series, Johns Hopkins Oncology Center, Baltimore, Maryland.

March, 1989, Advances in Pediatrics, Cook County Graduate School of Medicine, Chicago, Illinois.

July, 1989, Pediatric Grand Rounds, Columbus Hospital, Chicago, Illinois.

October, 1989, XIVth Symposium of the International Association for Comparative Research on Leukemia and Related

Diseases, Vail, Colorado.

of 32

January, 1990, Pediatric Grand Rounds, Oncology Grand Rounds, University of Wisconsin-Madison Medical School,

Department of Pediatrics and Comprehensive Cancer Center, Madison, Wisconsin.

February, 1990, Pediatric Grand Rounds, Illinois Masonic Hospital, Chicago, Illinois.

March, 1990, Pediatric Grand Rounds, Medical Oncology Grand Rounds, Yale School of Medicine, Department of Pediatrics

and Comprehensive Cancer Center, New Haven, Connecticut.

May, 1990, Meet the Professor, American Society of Clinical Oncology, Washington, D.C.

June, 1990, Fourth International Conference on Malignant Lymphoma, Lugano, Switzerland

August 31, 1990, Founder's Day Address, Northwestern University Medical School, Chicago, Illinois.

September, 1990, American Cancer Society Workshop on Mass Screening for Neuroblastoma, Chicago, Illinois.

February, 1991, Pediatric Section, 38th Annual Meeting, Puerto Rico Medical Association, San Juan, PR.

September, 1991, American Cancer Society Workshop on Children and Cancer, Naples, Florida.

November, 1991, Seminar on Rehabilitation of the Cancer Patient. Late Consequences of Childhood Cancer and its

Treatment. Rehabilitation Institute of Chicago.

February, 1992, Visiting Professor, Tripler Army Medical Center and Kapiolani Children's Medical Center, Honolulu

February, 1992, International Symposium, III. Acute Leukemias. Prognostic Factors and Treatment Strategies, Münster,

Federal Republic of Germany.

June, 1992, Histopathobiology of Neoplasia Workshop, Keystone, Colorado.

July, 1992, Public Testimony, Senate Appropriations SubCommittee on Labor, HHS, and Education, Washington, D.C.

July, 1992, Grand Rounds, Milwaukee Children's Hospital, Milwaukee, Wisconsin.

September, 1992, Invited Speaker, Annual Meeting, American Society of Pediatric Hematology/Oncology, Chicago, Illinois.

October, 1992, Faculty Member, Advanced Course in Pediatric Oncology, held in conjunction with The XXIV Meeting of The

International Society of Pediatric Oncology, Hannover, Germany.

October, 1992, American Cancer Society Workshop on Adolescents and Young Adults with Cancer, Atlanta, Georgia.

March, 1993, Topics in Pediatric Hematology and Oncology/Update, St. Petersburg, Florida.

April, 1993, Grand Rounds, Children's Hospital of Michigan, Detroit, Michigan.

April 1993, Keystone Symposium on Molecular and Cellular Biology, B and T Cell Lymphomas, Copper Mountain, Colorado.

June, 1993, Fifth International Conference on Malignant Lymphoma, Lugano, Switzerland.

June, 1993, Faculty participant, Russian-American Course on Basic and Clinical Research in Pediatric Hematology,

Oncology and Immunology, Moscow.

September, 1993, Workshop on Assignment of Risk Criteria for Acute Lymphoblastic Leukemia, NCI, NIH.

September, 1993, Malnati Symposium, Biology of Hematologic Malignancies:Implications for Diagnosis and Treatment in the

1990's. Northwestern University, Chicago, Illinois.

October, 1993, Lymphoma Symposium, XXV SIOP Meeting, San Francisco, California.

of 32

January, 1994, Invited Participant and Panel Moderator, Leukemia - Lymphoma Workshop, Jointly-Sponsored by NCI and

the Leukemia Society of America, Bethesda, Maryland.

May, 1994, Grand Rounds Rush-Presbyterian-St. Luke’s Medical Center/Cancer Center, Chicago, Illinois.

May, 1994, 97th Annual Meeting of Japan Pediatric Society, Sapporo, Japan.

May, 1994, Lectures/Tumor Conference/Grand Rounds, Kyoto/Hirosaki University School of Medicine, Hirosaki/Department

of Pediatrics, University of Tokyo/Tokyo Children's Cancer Study Group.

July, 1994, Histopathology of Neoplasia Workshop, Keystone, Colorado.

October, 1994, Faculty Member, Specialty Review Course in Pediatric Hematology/Oncology, The National Center for

Advanced Medical Education, (formerly the Cook County Graduate School of Medicine), Chicago, Illinois.

January, 1995, Grand Rounds, Children's Memorial Hospital, Chicago,Illinois.

July, 1995, Invited Presentation, President’s Cancer Panel, Chicago, Illinois.

September, 1995, 9th Meeting of The Mediterranean Blood Club, Cappadocia, Turkey.

October, 1995, Lymphoma, The Next Questions, San Antonio Texas.

February, 1996, Grand Rounds and Tumor Board, Children’s Hospital of Denver, Colorado.

December, 1996, Meet the Professor, American Society of Hematology Annual Meeting, Orlando, Florida.

September, 1997, XXIXth

Meeting International Society of Pediatric Oncology (SIOP), Istanbul, Turkey.

August, 1998, VI Congresso Brasileiro de Oncologia Pediatrica,Guaruja, Brazil.

August, 1998, XVII UICC International Cancer Congress, Rio de Janeiro, Brazil.

September, 1998, Specialty Review Course in Pediatric Hematology/Oncology, The National Center for Advanced Medical

Education.

March, 1999, Canadian Pacific Visiting Professor, Hospital for Sick Children, Toronto, Canada.

April, 2000, Ask the Experts, Public forum, American Association of Cancer Research, 91st Annual Meeting, San Francisco,

California.

March/April,2000, Ask the Experts Panel and Member Advisory Board to Home Box Office (HBO) public service information

special “Cancer: Evolution to Revolution”, telecast and webcast http://www.HBO.com, Lovett Productions Inc, HBO.

June, 2000, Cook Children’s Medical Center, Fort Worth, Texas.

July, 2000, Grand Rounds, Rush Medical Center, Chicago, Illinois.

July, 2000, Invited Public Testimony, Panel on Ethical and Policy Issues in the Oversight of Human Subjects Research.

National Bioethics Advisory Commission, Washington, DC.

November, 2000, Swiss Institute for Applied Cancer Research, Lucerne, Switzerland.

April, 2001, Invited Guest Speaker, Pediatric Subcommittee Oncologic Drugs Advisory Committee, Food and Drug

Administration, Rockville, Maryland.

May, 2001, Invited Faculty, Education Program, American Society of Clinical Oncology Annual Meeting, San Francisco.

July, 2001, Invited Guest Speaker, Institute of Medicine, National Cancer Policy Board Meeting, New York City

http://www.hbo.com/

of 32

August, 2001, The Helen DeVos Distinguished Lectureship, DeVos Children’s Hospital, Grand Rapids, Michigan

September, 2001, Brigid G. Leventhal Memorial Lectureship, Johns Hopkins Oncology Center, Baltimore, Maryland

October, 2001, Invited Faculty, American Academy of Pediatrics, National Conference and Exhibition, San Francisco

September 2002, Annual Pediatric Hematology/Oncology Symposium, AFLAC Cancer Center and Blood Disorders

Service of Children’s Healthcare of Atlanta, Georgia

February, 2003, Pediatric Grand Rounds, MD Anderson Hospital and Tumor Institute, Houston, Texas

March, 2003, Invited Speaker, Clinical Trials Third Annual Symposium: Benefits and Barriers, University of Texas

Health Science Center at San Antonio, School of Nursing

March 4, 2003, Invited Speaker, Second Annual Research Colloquium, University of Texas Health Science Center at San

Antonio, School of Nursing

April, 2003, Pediatric Hematology/Oncology Grand Rounds, Dallas Children’s Hospital, UT Southwestern Medical

School

August, 2003 and August 2007, Invited Faculty, American Society of Hematology Clinical Research Training Institute,

Laguna Cliffs, Dana Point, California

April, 2005, Co-Chair, New Concepts in Organ-Site Research Session, American Association of Cancer Research Annual

Meeting, Anaheim, California

May, 2005, Invited Participant, NCI-ACS Childhood Cancer Targeted Therapeutics Workshop, Washington.

June, 2005, Panelist and Subcommittee Chair, ASH/FDA Workshop on Clinical Endpoints in Acute Leukemia,

Washington.

February, 2006, Invited Participant, NCI Translational Research Working Group (TRWG) Roundtable, Phoenix, Arizona.

March, 2007, Invited Member, Lymphoma Task Force, American Joint Commission on Cancer (AJCC) Staging Meeting,

Chicago.

October, 2007, Invited Speaker, International Medical Sciences Academy, Manipal, India.

June, 2010, Pediatric Oncology Award Lecture, American Society of Clinical OncologyMeeting, Chicago

Septemnber, 2011, Invited Speaker, Symposium celebrating 30 years of the pediatric hematology-oncology unit, Centre

Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland

June, 2012, Special 50th

Anniversary speaker, Danny Thomas Lecture Series, St. Jude Childrens’ Research Hospital,

Memphis, Tennessee

of 32

Grants Past:

NIH, NCI P01 CA20180 (10-12), Leukemia Program Project, 10/1/87-4/30/89, Sharon B. Murphy, M.D., Principal

Investigator, 60% effort, Total Direct Costs, first year $964,678.

NIH, NCI U10 CA07431-(28-32), Pediatric Oncology Group Cooperative Agreement, 1/1/91-12/31/95, Sharon B. Murphy,

M.D., Principal Investigator, 15% Effort, Children’s Memorial Hospital, Total Direct Costs $101,784 First Year. Principal

Investigator status transferred to Morris Kletzel, M.D. as of 10/93.

NIH, NCI U01 CA55727-01A, Childhood Cancer Survivor Study, 4/1/93-3/31/98, L. Robison, J., Principal Investigators,

Total First Year Direct Costs $2,389,718 Sub-contract Agreement with University of Minnesota, 10% Effort -Sharon B.

Murphy, Principal Investigator for Children's Memorial Hospital, Sub-budget $40,934 first year direct costs; 6/1/94 - 5/31/95

(-02 year) $37,574 Direct Costs. Relinquished at end of -02 year voluntarily.

NIH, NCI R01 CA55507, Pediatric AIDS/Lymphoma Network, 7/16/91-6/30/95, First Year Direct Costs $235, 284, Sharon B.

Murphy, M.D., Principal Investigator, 20% Effort.

NIH, NCI R01 CA56296-01A1, Epidemiologic Study of Pediatric HIV-related Lymphomas, 9/1/92-8/31/96, Brad Pollock,

Ph.D., Principal Investigator, Sharon B. Murphy, M.D., Co-Principal Investigator, 10% Effort, current year (9/1/95-8/31/96),

Total Direct Costs, annually-04 year, $234,516

NIH, NCI U10 CA30969, Pediatric Oncology Group, Operations Office, 1/1/96-12/31/2000, Sharon B. Murphy, M.D.,

Principal Investigator, 50% effort, First Year Direct Costs $2,380,112, Total Direct Costs $14,251,777. (Award extended and

transferred to Children’s Oncology Group 1/01).

NIH, NCI UO1 CA57745 (7/17/96-6/30/01), Pediatric Oncology Group, Phase I Trials, Sharon B. Murphy, M.D., Principal

Investigator, 10% effort, First Year Direct Costs $272,244. (Award extended and transferred to Children’s Oncology Group

6/01).

NIH, NCI U10 CA37379 (6/1/97-5/31/02) Pediatric Oncology Group as a CCOP Research Base, Brad Pollock, Ph.D.,

Principal Investigator, 5% effort, First Year Direct Costs $390,125, Sharon B. Murphy, Co-Investigator. (Transferred to

Children’s Oncology Group 6/01).

NIH, NCI P30 CA60553, Robert H. Lurie Comprehensive Cancer Center of Northwestern University,Cancer Center Core

Support Grant, (years 9-13, 8/1/01-7/31/05), Steven T. Rosen, M.D., Principal Investigator, Total Cost $24,404,588, First

YearDirect Costs,$3,296,770. Sharon B. Murphy, M.D., Pediatric Oncology Program Leader, 5% effort. (Transferred to Dr.

S. Cohn, effective 10/02).

NIH, NCI T32 CA79447 (1/13/99-12/31/03), Clinical Oncology Research Training Program, Steve Rosen, MD, PI, First Year

Direct Costs $182,808 Sharon B. Murphy, MD., Co-Director. (Transferred to Dr. D. Walterhouse, effective 10/02).

CURRICULUM VITAE - Harvard Medical School...3/20/2014 CURRICULUM VITAE Name: SHARON BOEHM MURPHY...

Documents

Transcript of CURRICULUM VITAE - Harvard Medical School...3/20/2014 CURRICULUM VITAE Name: SHARON BOEHM MURPHY...